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ABSTRACT
The causes of hip osteoarthritis (OA) appear to be heterogeneous with genetic, environ-
mental and lifestyle-related risk factors influencing the development of the disease. Hip OA
causes pain and disability, reducing the quality of life, and there is no treatment to prevent
or cure it after the onset of development. Therefore, the reduction of pain and improvement
in physical function are important outcomes when evaluating the effective treatment strat-
egy for hip OA.
The aim of the study was to identify independent risk factors for developing hip OA in a
prospective population-based study with a follow-up period of up to 22 years.  An assess-
ment was made of the short-term and long-term effectiveness of exercise-based rehabilita-
tion in reducing pain, maintaining physical function and limiting direct health care costs
attributable to hip OA in a two-year randomized controlled trial. A further aim was to iden-
tify predictors of pain and disability in hip OA. Objective and subjective physical function
were investigated with a battery of physical function tests and questionnaires, including
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and RAND
36-Item Health Survey (RAND-36).
Heavy manual work and musculoskeletal injuries were found to predict the develop-
ment of hip OA in the 22-year follow-up study. Factors explaining and predicting disability
and pain in hip OA are multidimensional and no single factor was found to be more impor-
tant than any other. Higher educational levels, absence of knee OA and comorbidities, su-
pervised exercise training and habitual physical activity predicted a lower prevalence of
pain and a better functional status in patients with hip OA.
Exercise therapy for hip OA had no significant effect on self-reported pain or general
physical health, but it slightly improved self-reported physical function in individuals with
hip OA. Based on these findings, the clinical importance of exercise therapy remains uncer-
tain and it is unclear whether exercise training translates into true improvement in physical
performance or reduced health care costs.
National Library of Medicine Classification: WE 860, WL 704
Medical Subject Headings: Exercise Therapy/economics: Osteoarthritis, Hip; Pain/rehabilitation; Risk factors;
Treatment Outcome
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TIIVISTELMÄ
Lonkan nivelrikon syyt ovat moninaisia. Taudin syntyyn vaikuttavat geneettiset sekä ym-
päristöön ja elintapoihin liittyvät tekijät. Lonkan nivelrikko aiheuttaa kipua ja rajoittaa to-
imintakykyä eikä sen etenemistä kyetä estämään tai parantamaan enää taudin syntymisen
jälkeen. Sen vuoksi, arvioitaessa hoidon vaikuttavuutta, lonkan nivelrikon hyvän hoidon
tunnusmerkit tulisi olla elämänlaadun parantaminen lievittämällä kipua ja ylläpitämällä
fyysistä toimintakykyä.
Tutkimuksen tavoitteena oli löytää lonkan nivelrikkoa ennustavia tekijöitä 22 vuotta kes-
täneellä väestötutkimuksella ja arvioida terapeuttisen harjoittelun vaikutuksia kipuun ja
toimintakykyyn sekä lonkan nivelrikon aiheuttamiin välittömiin terveydenhuollon kustan-
nuksiin satunnaistetulla kontrolloidulla tutkimuksella. Lisäksi pyrittiin löytämään mene-
telmiä, joilla kivun lisääntymistä ja toimintakyvyn heikkenemistä olisi mahdollista en-
nustaa taudin edetessä. Fyysistä toimintakykyä tutkittiin objektiivisin ja subjektiivisin me-
netelmin toimintakykytesteillä ja kyselyillä kuten Western Ontario and McMaster Universi-
ties Osteoarthritis Index (WOMAC) ja RAND 36-Item Health Survey (RAND-36) mittareil-
la.
Väestöpohjaisen 22-vuotisen seurantatutkimuksen perusteella lonkan nivelrikon kehit-
tymistä ennustaviksi tekijöiksi osoittautuivat raskas työn fyysinen kuormitus sekä tuki- ja
liikuntaelinten vammat. Lonkan nivelrikossa toimintakykyyn ja kipuun vaikuttavat monet
tekijät, joista mikään ei näyttänyt olevan muita tärkeämpi nivelrikon oireiden etenemistä tai
toimintakyvyn laskua ennustava tekijä. Korkeampi koulutustaso, polvinivelrikon ja mui-
den sairauksien puuttuminen, ohjattu terapeuttinen harjoittelu ja säännöllinen liikunta en-
nustivat vähäisempää kipua ja parempaa toimintakykyä.
Terapeuttinen harjoittelu ei merkittävästi vaikuttanut potilaiden lonkkanivelen kiputun-
temuksiin tai fyysiseen terveydentilaan liittyvään elämänlaatuun, mutta potilaiden oman
arvion mukaan se saattoi jonkin verran parantaa heidän fyysistä toimintakykyään. Näiden
havaintojen perusteella terapeuttisen harjoittelun merkitys on epävarma ja on epäselvää,
saadaanko siitä todennettavaa hyötyä tai säästöjä terveydenhoidon välittömissä kustan-
nuksissa lonkkanivelrikkoa sairastavilla potilailla.
Yleinen Suomalainen asiasanasto: riskitekijät; harjoittelu; nivelrikko; lonkka, kipu; toimintakyky.
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1 Introduction
Osteoarthritis (OA) is the most common form of joint disease worldwide, with an age-
associated increase in both incidence and prevalence (Oliveria et al. 1995). It is therefore one
of the most common causes of physical disability in the elderly population (Dawson et al.
2004). OA is characterised by degeneration of articular cartilage, joint space narrowing,
pain and disability (O’Reilly and Doherty 2003). It has been estimated that hip OA affects
approximately 7%-25% of individuals in the over 55 year group and is more common
among  males  than  females  (Felson  et  al.  2000).  The  social  and  economic  impact  of  OA  is
substantial and consequently affects the quality of life at the individual level (Reginster
2002). In 2003 the annual cost of hip joint replacement operations in Finland totaled nearly
70 million € without taking into account post-surgery rehabilitation (Remes et al. 2007). To-
day in Finland 6% of all disability pension payouts can be attributed to OA. In addition it is
estimated that the direct and indirect costs of OA in Finland are nearly 1 billion € per year
(Heliövaara and Paavolainen 2008). The number of people with OA disability is expected to
double by the year 2020 (Bradley 1991, Elders 2000), thereby further increasing the already
substantial economic impact of OA.
It is important to understand potential determinants and modifiable risk factors of hip
OA in order to develop efficient prevention strategies for hip OA or the treatment of its
consequences both at the individual and population levels. The causes of hip OA appear to
be heterogeneous with genetic, environmental and lifestyle-related risk factors influencing
the development of the disease (Felson 1998). Ageing is the most consistent risk factor for
the development of hip OA in both males and females (Heliövaara et al. 1993b, Tepper and
Hochberg 1993, Karlson et al. 2003). Twin studies have found a strong genetic link to hip
OA (Lanyon et al. 2000, MacGregor et al. 2000). An individual may have an inherited pre-
disposition to the disease, without any symptoms of OA (Spector and MacGregor 2004) but
is only likely to develop it when a biomechanical insult e.g. joint injury occurs (Felson et al.
2000, Lievense et al. 2003). OA can either be a consequence of an abnormal mechanical load
on a healthy joint or of a normal mechanical pressure on unhealthy cartilage tissue (Nuki
and Salter 2007). Moderate evidence exists for the association of hip OA with obesity
(Lievense et al. 2002) or sporting activities (Lievense et al. 2003) or a history of physical load
work (Lievense et al. 2001, Jensen 2008) or physical load leisure activities (Vingård et al.
1997). Several studies also advocate that injury is a major risk factor (Heliövaara et al.
1993b, Tepper and Hochberg 1993, Cooper et al. 1998, Lau et al. 2000). However, most of
these studies regarding the potential risk factors of hip OA have been cross-sectional (Tep-
per and Hochberg 1993, Lau et al. 2000) or at their best prospective, with a short follow-up
period (Teperi et al 1993, Cooper et al. 1998, Lau et al. 2000).
The natural history of OA is poorly understood and there is no preventive treatment or
cure after the onset of development (Brandt et al. 2006). Therefore focus on the conse-
quences  of  hip  OA  such  as  reduction  of  pain  and  improvement  in  physical  function  and
quality of life are important in the evaluation the most effective treatment strategy. Accord-
ing to evidence-based recommendations for the management of OA, exercise is a com-
monly included as an effective treatment for patients with lower limb OA (Arokoski et al.
2012, Hochberg et al. 2012, Zhang et al. 2008, Zhang et al. 2010). The American College of
Rheumatology (ACR) subcommittee on OA guidelines, the Osteoarthritis Research Society
International (OARSI) Group and the Consensus of a Multidisciplinary Guideline Devel-
opment  Group  (MOVE  Consensus)  have  all  concluded  that  strength  training  and  aerobic
exercise can both reduce pain and improve function and health status in patients with hip
OA (Hochberg et al. 2012, Zhang et al. 2008, Zhang et al. 2010, Roddy et al. 2005).
2However, these recommendations are based on a very low level of scientific evidence and
many unanswered questions remain concerning the long-term benefits of treatment, adher-
ence to the exercise programme as well as the overall cost-effectiveness of this approach.
The aim of  this  doctoral  thesis  was  to  identify  potential  risk  factors  for  hip OA and to
evaluate their roles in its etiology in a population-based 22-year follow-up study. Another
purpose of the thesis was to assess the short-term and long-term effectiveness of exercise-
based rehabilitation in reducing pain, maintaining physical function and limiting direct
costs to health care systems attributable to hip OA during a two year randomized con-
trolled trial.
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2.1. PATHOGENESIS OF HIP OSTEOARTHRITIS
The hip joint is a synovial joint formed by the articulation of the rounded head of the femur
and the cup-like acetabulum of the pelvis.  The hip joint is reinforced by five ligaments,  of
which four are extracapsular and one is intracapsular. The strong but loose fibrosus capsule
of the hip joint permits the hip joint to have a large range of motion (ROM) and jet support
the  weight  of  the  body,  arms and head.  Both joint  surfaces  are  covered with a  strong but
lubricated layer called articular hyalinen cartilage. The cartilage is composed of four dis-
tinct zones, characterised by chondrocytes and collagen fibers. Chondocytes are responsible
for synthesising the cartilage extracellular matrix. The extracellular matrix is composed of
collagen (10 to 20%), proteoglycans (10 to 20%) and water (65 to 80%). The viscoelastic be-
havior of cartilage is dependent on the water binding properties of the matrix protein-
polysaccarides (Sharma and Berenbaum 2007).
OA is a condition that represents a pathological imbalance of degenerative and regenera-
tive processes of joint structures. Any consideration of a pathologic process of osteoarthritis
begins with articular cartilage, but ultimately the disease affects the whole joint, including
cartilage, subchondral bone, synovium and periarticular soft tissues (Brandt et al. 2006,
Goldring and Goldring 2007) (Figure 1).
Biochemically OA can be seen as a process where the deterioration of the extracellular
matrix starts to predominate over cartilage repair activities (Goldring and Goldring 2007).
In early stages of OA both the degenerative and regenerative enzymes of cartilage and as-
sociated genes are activated in the chondrocytes. Later on the proteolytic breakdown pre-
dominates, when proteolytic enzymes such as proteoglycans, collagens and metallopro-
teinases (e.g. stromelysin and collagenase) increase and participate in the degradation of
them (Lammi et al. 2008). The metalloproteinases are activated by inflammatory cytokines,
such as interleukin-1 and tumor necrosis factor-΅, nitric oxide and synovial inflammatory
transmitters. Adipokine hormones e.g. leptin and adiponectin have been identified as a
regulatory factors in inflammation and arthritis (Neumann et al. 2011, Comez et al. 2011).
Leptin and adiponectin are found to be synthesized by white adipose tissue. Recent studies
show that leptin and adiponectin are possible links between obesity and OA, since these are
increased when obesity occurs and these hormones induce the production of matrix matal-
loproteinases, proinflammatory cytokines and nitric oxide in chondrocytes (Vuolteenaho et
al. 2009, Koskinen et al. 2011,). Structurally the decrease of the proteoglycan concentration
in cartilage, collagen network disorganisation and softening are signs of cartilage injury
and OA (Buckwalter 1995, Arokoski et al. 2000).
4Figure 1.The pathophysiological findings involved in hip OA.
OA can either be a consequence of an abnormal mechanical load on a healthy joint or of a
normal  mechanical  pressure  on  unhealthy  cartilage  tissue  (Nuki  and  Salter  2007).  The
highly specific microscopic anatomy and physiology of articular cartilage can be disrupted
by small, superficial injuries, even without immediate cartilage loss. Superficial damage
will injure chondrocytes, limit their metabolic capacity for repair and lead to decreased pro-
teoglycan concentration, increased hydration and altered fibrillar organisation of collagen.
This leads to biochemical consequences which eventually manifests themselves as OA; joint
structural changes and pain (Nuki and Salter 2007, Goldring and Goldring 2007).
Structural, biochemical and biomechanical changes in the subchondral bone are a major
characteristic of OA (Arokoski et al. 2000). Structural alterations manisfest themselves as
osteophyte formation and subchondral sclerosis, which are important in radiological diag-
nosis. Subchondral bone changes not only occur during the final stage of OA but also at the
onset of the disease; possibly even prior to cartilage degradation becoming evident. This
early phase bone loss due to extensive remodeling may precede later observed sclerosis. A
biochemical and biomechanical mutual interaction between subchondral bone and the
overlaying cartilage is nowadays considered attributable to the progressive character of OA
(Radin and Rose 1986). On the other hand, osteophytes that are considered to develop early
in  the  disease  and  are  included  in  the  first  measurement  of  Kellgren-Lawrence  (K-L)  OA
grading system may also develop later in the joint degenerative process.
OA is not considered a classic inflammatory arthropathy due to the lack of systemic
manifestations of inflammation. However, OA is frequently associated with signs and
symptoms of inflammation including joint pain, swelling and stiffness leading to a signifi-
cant functional impairment and disability (Felson 2006). Synovial inflammation is a factor
that is likely to contribute to deregulation of chondrocyte function, leading to an imbalance
between the catabolic and anabolic activities of the chondrocyte in remodeling the cartilage
extracellular matrix (Loeser et al. 2012).
Hip  OA  can  also  lead  to  changes  in  periarticular  muscles  (Liikavainio  and  Arokoski
2009). The cross sectional area of the pelvic or thigh muscles is significantly lower in the
more severely affected hip compared to the hip on the better or healthy side of subjects
with hip OA (Arokoski et al. 2002, Rasch et al. 2007, Grimaldi et al. 2009). In hip OA there is
a selective atrophy of type II muscle fibers in comparison to healthy subjects (Amaro et al.
2007). Several mechanisms have been proposed as being involved in muscle weakness in
OA: firstly the disuse atrophy of muscles due to joint pain; secondly reflex inhibition of
5muscles moving the affected joint; thirdly incapacity to fully activate the muscle resulting
in decreased force production (Hurley 1999, Mizner et al. 2005).
Despite numerous identified predisposing factors and the involvement of mechanics, the
exact pathogenesis is still the subject of debate and research. Specifically, the very early
changes are largely unknown because they cannot be studied easily in humans. This is at-
tributable to the changes appearing well in advance of OA diagnosis in clinical practice.
2.2 EPIDEMIOLOGY AND RISK FACTORS OF HIP OSTEOARTHRITIS
2.2.1 Prevalence of hip osteoarthritis
Although OA may affect any joint in the body, it most commonly affects the knee followed
closely by the hip (Felson 1990). Radiographic primary hip OA is in approximately 5% to
10% of the adult population (Dagenais et al. 2009). However, due to heterogeneous
radiographic methods of diagnosis and divergent criteria, the overall estimates of
radiographic primary hip OA vary from 0.9% to 27.0% in different populations (Dagenais et
al. 2009).
The prevalence of radiographic hip OA has been best studied in population surveys. The
Framingham Study advocates that radiographic hip OA occurs in 3-4 per cent of
individuals aged 63 and over (Felson 1988). Symptomatic OA is generally defined as
frequent joint pain and structural alterations in radiography. A recently published
population based survey, assessing the prevalence of symptomatic and radiographic hip
OA in a multiregional sample in France, estimated that hip OA prevalence according to age
class ranged from 0.9% to 3.9% for men and 0.7% to 5.1% for women (Guillemin et al. 2011).
According to the Finnish Health 2000 Survey, the age-adjusted prevalence of clinically
diagnosed hip OA was 5.7% in males and 4.6% in females (Arokoski et al. 2007). The
prevalence was consistently higher in males except in the 75 to 84 year age group where it
was  the  same  for  both  sexes.  In  men  the  prevalence  of  hip  OA  ranged  from  0.5%  in  the
youngest age group to 39.8% in the oldest (those aged 85 years or more) and in women
from 0.4% in the youngest to 24.5% in oldest. The age-adjusted prevalence of hip OA
showed negative correlation with years of education in both genders. Among the Finnish
population the prevalence of hip OA has not been changed during 20 years (Heliövaara et
al. 1993a, Arokoski et al. 2007), whereas the prevalence has decreased in middle-age groups
(from 45 to 64 years) and increased in the oldest (those aged 85 years or more).
2.2.2 Risk factors
Although the pathogenesis of hip OA remains partly unknown, there are several risk fac-
tors that may predispose to OA (Felson 1998). Hip OA is considered a multifactorial disease
that involves interplay of several risk factors e.g. age, gender, genetics, dysplasia, mechani-
cal work load, obesity, joint injury or sporting activities. Epidemiological studies indicate
that  OA of  the  hip frequently  occurs  in  the  absence  of  OA in  other  large  joints.  This  sug-
gests that local biomechanical factors are important in its pathogenesis (Cushnaghan and
Dieppe 1991, Ecker et al. 2007, Wright et al. 2009). The details of the results from previous
epidemiological studies concerning the risk factors for hip OA are presented in Table 1. The
most consistent risk factors are considered to be age, genetics, congenital disorders of the
hip joint, overweight or obesity, occupational and sporting related overload of the hip joint
and joint injuries.
2.2.2.1 Age
The prevalence of hip OA correlates strongly with age and it starts to increase in middle
age in both genders (Heliövaara et al. 1993b, Arokoski et al. 2007, Dagenais et al. 2009,
Guillemin et al. 2011). Geographic or ethnic differences in prevalence estimates have also
6been reported (Yoshimura et al. 1998, Inoue et al. 2000, Nevitt et al. 2002) but discrepant
estimates of prevalence mainly result from variable definitions of hip OA.
According to the Finnish Health 2000 Survey, the prevalence of radiographic and clinical
hip OA increases with age in both males and females (Arokoski et al. 2007). A clear trend
towards increasing prevalence of radiographic hip OA with advancing age from 35 to 85
years was also confirmed in a recent systematic review (Dagenais et al. 2009). The mean
increase in the prevalence of radiographic hip OA was 1.2% for each 5-year age group from
35 to 85 years.
2.2.2.2 Gender and hormonal factors
The prevalence of hip OA in females increases after menopause (van Saase et al. 1989,
Felson et al. 2000, Guillemin et al. 2011). This observation has contributed to the theory that
decreased oestrogen levels play a role in OA pathogenesis (Felson 1988). Some cross-
sectional studies have found that oestrogen replacement therapy is associated with lower
rates of hip or knee OA (Nevitt et al. 1996, Spector et al. 1997).  However, the inverse
relationship between oestrogen use and OA has been inconsistent in epidemiological
studies (Nevitt et al. 1996, Spector et al. 1997, Sandmark et al. 1999, Jacobsen et al. 2004).
Data from the First National Health and Nutrition Survey (NHANES I) in the United States
suggest that etiological factors associated with hip OA may differ between males and
females and differ between unilateral and bilateral hip OA (Tepper and Hochberg 1993). A
recent population-based survey in France confirmed that the prevalence of symptomatic
hip OA increases with age in both genders (Guillemin et al. 2011). The age-related preva-
lence of symptomatic hip OA of radiographic K-L grade ǃ 2 ranged from 0.9% to 3.9% in
men and from 0.7% to 5.1% in women.
2.2.2.3 Genetic factors and race
Genetic  factors  appear  to  influence  the  risk  of  developing  primary  hip  OA.  Twin  studies
have shown a strong contribution of genetic factors in the development of hip OA (Lanyon
et al. 2000, MacGregor et al. 2000). Similar to many common complex diseases and
disorders, the genetic background of OA has not yet been characterised. The manner in
which genes specifically influence the incidence and progression of OA and associated
disability is difficult to ascertain from the available data. The genetic background of OA is
likely  to  be  polygenic  with  multiple  gene  variants  each  of  them  having  a  small  effect
(Valdes et al. 2011). Different genetic associations are seen in European descent compared
with Asian populations. In European descendants three genetic variants have been
associated with genome wide significance in large joint OA (Valdes et al. 2008). The
variants implicated in OA among Caucasians map to the GDF5 gene and the MCF2L gene.
GDF5 is a chondroprotective growth factor and MCF2L is associated with neurotrophin
regulated cell motility of neurons and thus potentially affecting nociception (Kerkhof et al.
2010).  More specific outcome measures of OA are required to assist with a better
understanding of the effects of genetic factors on different stages of joint degradation.
OA varies across racial groups, including differences in prevalence and radiographic
features and differences in pain and function (Allen et al. 2010). Regarding the prevalence
of  OA,  prior  studies  indicate  hip  and  OA  is  less  common  among  Chinese  individuals
compared with U.S. Caucasians (Newitt et al. 2002) and that self-reported OA may be less
common among Hispanics than Caucasians in the United States (Allen 2010).
2.2.2.4 Congenital disorders
Childhood disorders of the hip joint, such as congenital hip dysplasia, Legg-Calve-Perthes
disease or slipped capital femoral epiphyses, are modifiable risk factors, if identified early
(Harris 1986, Lane et al. 2000). In adults evidence of hip dysplasia in X-rays is strongly as-
sociated with prevalent hip OA (Jacobsen 2004). In the Rotterdam Study (Rejma et al. 2005)
7examined males and females of at least 55 years of age with no signs of radiographic OA of
the hip at baseline. This study found that acetabular dysplasia was a strong independent
determinant of incident radiographic OA of the hip amongst the elderly population. There
is also evidence that mild acetabular dysplasia (McWilliams et al. 2010) and femoroacetabu-
lar impingement as a consequence of abnormal contact between the acetabular rim and
femoral head-neck junction, resulting in damage to the chondral surface and labrum, can
lead to the development of OA of the hip (Beck et al. 2005, Ganz et al. 2008).
2.2.2.5 Overweight and obesity
Excessive weight or body mass index (BMI) strongly increases the risk of developing
symptomatic and radiographic knee OA (Spector et al. 1994, Cooper et al. 2000). Being
overweight adds higher loads on weight-bearing joints and could thereby contribute to the
development of hip OA. However, the relation of excessive weight or obesity with hip OA
is not as well defined as the association of them with knee OA. Several cross-sectional
(Olsen et al. 1994, Flugsrud et al. 2006, Franklin 2009) and cohort studies (Tepper and
Hochberg 1993, Flugsrud et al. 2002, Karlson et al. 2003, Järvholm et al. 2005, Liu et al. 2007)
have  indicated  an  increased  risk  of  hip  OA  linked  to  obesity.  A  number  of  others  have
failed to support the association (Saville and Dickson 1968, Lau et al. 2000). A recent meta-
analysis (Jiang et al. 2011) displayed that the risk of hip OA increases with BMI and a dose-
response relationship exists. A 5-unit increase in BMI was associated with an 11% increased
risk of hip OA. It has been suggested that obesity not only increases the risk of radiographic
hip OA but also symptomatic hip OA. In the population-based Mini-Finland Health
Survey,  BMI  was  directly  proportional  to  the  prevalence  of  bilateral  hip  OA.  The  survey
showed that individuals with a BMI > 35 had a 2.8 times higher risk of having bilateral hip
OA  than  those  with  a  BMI  <  25,  while  the  association  of  BMI  with  the  prevalence  of
unilateral hip OA was much weaker (Heliövaara et al. 1993b).
A population-based prospective cohort study assessed incidences of knee and hip joint
replacements due to OA in relation to different body mass measures including body
weight, BMI, waist circumference and percentage of body fat (Locmander et al.  2008). BMI
was associated with a much higher relative risk than waist circumference or percentage fat.
This  suggests  that  being overweight  is  a  particularly  important  risk  factor  for  developing
knee and hip OA. BMI, adipose tissue mass and central adiposity (waist circumference and
waist to hip ratio) were directly related to the risk of primary knee and hip joint
replacements for OA, whereas waist circumference was directly associated only with the
risk of knee replacement (Wang et al. 2009).
2.2.2.6 Occupation
The association between heavy manual work and an increased risk of radiographic hip OA
has been demonstrated in several cross-sectional studies amongst males (Tyyppö 1985,
Jacobsson et al. 1987, Croft et al. 1992, Olsen et al. 1994, Coggon et al. 1998, Cvijetic et al.
1999, Lau et al. 2000) and females (Vingård et al. 1997, Tyyppö 1985) as well as in prospec-
tive studies among males (Vingård 1991, Thelin and Holmberg 2007) and in both sexes
(Flugsrud  et  al.  2002).  A  number  of  occupations,  such  as  construction  work,  coal  mining,
fire fighting, abattoir work, ballet dancing and farming have been associated with an ele-
vated risk (Andersson 1984, Andersson et al. 1989, Vingård 1991, Croft et al. 1992). Addi-
tionally the association of recurrent exposure to manual load handling with radiographic
and clinical hip OA was assessed in a Finnish population based cross-sectional study in the
Health 2000 Survey (Kaila-Kangas et al. 2011).  The research group concluded that em-
ployment history involving the manual handling of loads of over 20kg was strongly associ-
ated with hip OA in both genders aged 30 to 97. The problem became apparent after ap-
proximately 12 years exposure in all age groups except the youngest (from 30 to 39 years).
Researchers suggest that one explanation for the result might be that hip OA takes a long
8time to develop and that young people do not generally choose to work in physically de-
manding occupations.  Moreover,  the  study indicated that  hip OA is  much more common
among working-aged males than females. A recently published systematic review also
summarised that individuals who had been involved in occupational heavy lifting had a
significantly  increased risk  of  hip OA in  12  of  14  studies  with  different  study designs.  As
many as 13 of the 14 studies displayed a significantly increased risk of hip OA among
farmers (Jensen 2008). When completely removing substantial physical labour is an unreal-
istic goal, minor alterations in ergonomics, training in correct lifting techniques and the use
of mechanical handling equipment may reduce occupation related OA risk.
2.2.2.7 Sporting activities
Most  studies  support  the  view  that  regular  physical  activity  does  not  increase  the  risk  of
development or progression of hip OA (Lane et al. 1998). However, elite athletes have been
shown to have a 2 to 3 fold higher risk of radiologic OA of the knees and hips (Tveit et al.
2012). This suggests that the duration rather than frequency of training is important
(Spector et al. 1996). The results of other studies evaluating the risk of OA among
professional athletes indicates that male athletes have higher rates of hospital admission for
ankle, knee or hip OA than matched healthy male controls and OA changes commonly
manifests itself in athletes over 65 years of age (Kujala et al. 1994).
A recent prospective cohort study concluded that long-distance skiers have a higher risk
of subsequent arthroplasty of the knee and hip due to OA than individually matched con-
trols, who were not participating in long-distance ski races during the study period of 10
year (Michaelsson et al. 2011). Moreover, one systematic review concluded that there is
moderate evidence for a direct association between sporting activity and hip OA (Lievense
et al. 2003), but that the evidence tends to weaken due to the heterogeneity of the study
populations and outcome measures. Impact of physical activity on the etiology and prog-
nosis of OA also seems to depend on the type, intensity and components of physical activ-
ity (Michaelsson et al. 2011).
2.2.2.8 Joint injury
Joint injuries in sports significantly increase the risk of knee OA (Felson 1990, Roos 2005). A
similar trend for hip injuries leading to radiographic hip OA has also been reported in
cross-sectional studies (Cooper et al. 1998, Lau et al. 2000). There is only one cohort study
showing the direct association between hip traumas and an increased risk of radiographic
hip OA (Tepper and Hochberg 1993). In a retrospective analysis of the Mini-Finland Health
Survey  individuals  with  a  history  of  traumatic  lower-limb  injury  had  a  2.1-fold  risk  of
having unilateral hip OA, diagnosed either clinically or radiographically, and a 1.5-fold risk
of having bilateral hip OA (Heliövaara et al. 1993b).
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2.3 SYMPTOMS AND SIGNS OF HIP OSTEOARTHRITIS
2.3.1 Symptoms
The main symptoms of hip OA are pain, stiffness and altered function (van Baar et al. 1998).
Pain is the most dominant symptom in hip OA. Initially symptoms are typically aching in
nature, related to joint use, and relieved by rest. As OA progresses, pain may become more
persistent and occur at rest and at night. Interference with restorative sleep may further
aggravate the pain severity trough associated fatigue and lack of well-being. Typically the
gradual progression of pain is observed. Several studies have confirmed that the
association between radiologic OA and clinical symptoms is contradictory (Arokoski et al.
2004, Summers et al. 1988, Barker et al. 2004, Hall et al. 2006, Szebenyj et al. 2006). Pain,
caused by hip OA, correlates strongly with psychological variables such as anxiety and
depression (Davis et al. 1992, O’Reilly et al. 1998).
True hip pain is most commonly felt in the groin but can also present in the buttock and
often down the anteromedial tight to the knee (Lesher et al. 2008). Nearly half of patients
with radiological features of OA have no symptoms and vice versa (Hannan et al. 2000).
Since articular cartilage is aneural, early changes do not produce clinical signs unless
innervated tissue becomes involved. This is one reason for the late diagnosis of OA.
In comparison with other joints, such as the knee, pain from the hip is difficult to define,
for three possible reasons (Birrell et al. 2005): first, the joint is not superficial, so pain arising
from structures in and around of the hip joint can be felt  across a broader region; second,
pain from structures outside the hip, for example the low back, the groin and the urinary
and the genital tracks, may also be associated with pain in the hip region; third, it is unclear
whether there is a specific topographical area that can usually be distinguished as ‘the hip’.
In contrast to inflammatory arthritis, with its prolonged morning stiffness and worsened
pain in the morning, hip OA pain and stiffness tends to worsen as the day progresses.
The mechanism of pain production in OA remains unclear (Felson 2005, Hochman et al.
2011, Mease et al. 2011). However, the OA process may affect all intracapsular and
periarticular tissues of the synovial joint leading to various causes of pain. Pain during the
weight  bearing  is  typically  felt  maximally  deep  in  the  anterior  groin  (femoral  nerve),  but
may be referred over a wide area including the lateral thigh and buttock (sciatic nerve),
anterior  tight  and  knee  (obturator  nerve)  and  as  far  down  the  leg  as  ankle  (O’Reilly  and
Doherty 2003). Articular cartilage itself is aneural but there is rich sensory innervation in
other joint tissues. Raised intraosseus pressure, presumably secondary to venous
obstruction, is a suggested major cause of nocturnal pain in large OA joints (Arnoldi et al.
1975). Peripheral and central sensitisations have been suggested as two of the underlying
mechanisms of pain in OA (Felson 2005, Arendt-Nielsen et al. 2010). Continuous and
intense nociceptive input from the OA-damaged knee joint is assumed to play an important
role in pain mechanisms in OA (Felson 2005). Pain in hip OA seems to deteriorate slowly,
with limited evidence of worsening after three years of follow-up (van Dijk et al. 2006).
Patients report symptoms that limit their day-to-day activities, such as stair climbing,
walking and doing household chores (van Baar et al. 1998). The explanation for disability,
functional loss and muscle weakness is not always clear. The symptoms of hip OA diminish
the patient’s physical activity (Dekker et al. 2009, Veenhof et al. 2012) and quality of life
(O’Reilly and Doherty 2003).
The stiffness in hip OA is termed “inactivity stiffness” and contrasts with the prolonged
“morning stiffness” of rheumatoid arthritis. Stiffness in hip OA lasts less than 30 minutes
and occurs when the patient gets up and bears weight after a prolonged period of
immobility (Hooper and Moscowitz 2007).
Among self-reported measurement tools, assessing the level of symptoms caused by hip
OA, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
(Bellamy et al. 1988) and Lequesne (Lequesne 1991) questionnaires are the most used.
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WOMAC is a well-studied instrument with long established reliability and validity,
including the use of the subscales separately. It consists of three subscales; pain, stiffness
and function. The visual analogue scale (VAS) version allows the patients to estimate the
symptoms  by  marking  an  X  on  a  100  mm  long  line  (the  beginning  of  the  line  =  no
symptoms, the end of the line = worst possible symptoms). The Lequesne Index is a 10-
question survey with 5 questions pertaining to pain or discomfort; one question dealing
with maximum distance walked and 4 questions about activities of daily living. The total
questionnaire is scored on a 0 to 24 scale. Lower scores indicate that there is less functional
impairment.
2.3.2 Clinical findings
The visual observation of gait while the subject walks on a level surface shows an apparent
decreased  weight  bearing  on  the  involved  leg,  which  may  already  be  a  signal  of  hip  OA
(Hasan and Schuscelt 2010). A patient will often walk with a limp and wadding
Trendelenburg gait (a pelvis drop on either side during the stance phase of gait due to
muscle weakness of the abductors of the hip) may be evident during the later stages.
Additionally anterior groin palpation tenderness, lateral to the femoral pulsation, is
possible.
Although hip pain is common in the community, population studies have shown that it
has only a weak relationship with hip OA (Lawrence et al. 1989). Restriction of the ROM
has been proposed as a useful diagnostic tool (Cibulka and Threlkeld 2004) and hip joint
ROM has shown to be a sensitive marker of the radiographic severity of OA (Birrell  et al.
2001). The hips of the OA subjects have shown a 13% - 52% restriction of ROM compared to
those of healthy subjects (Arokoski et al. 2004). The largest relative differences are in this
order: extension; internal rotation; abduction; external rotation; adduction and flexion
(Arokoski et al. 2004).  Typically this is accompanied by pain with internal rotation of the
hip joint. A fixed flexion, external rotation deformity is the most usual end-stage symptom,
with compensatory exaggerated lumbar lordosis and pelvic tilt (O´Reilly and Doherty
2003).
Adequate muscle strength seems to be an important factor in maintaining the ability to
perform daily living activities in hip and knee OA (Liikavainio and Arokoski 2009). Patients
with hip OA have reported a reduction in isometric and isokinetic muscle strength of pelvic
and thigh muscles. This manifests itself in significantly lower abduction, adduction, and
flexion muscle strength (pelvic and thigh muscles) in comparison with the healthy age
matched controls (Arokoski et al. 2002). In this case muscle strength of the OA subjects was
68-87% of that in the controls. Rasch et al. (2007) showed in their studies, that a substantial
loss of strength and mass in the affected limb exists compared to the contra lateral (healthy)
side in patients with unilateral hip OA. This finding contributed to the reduced ambulatory
capacity of OA patients (Rash et al. 2007). Concurrently, Sueta et al. (2007) demonstrated a
marked side to side difference with decreased muscle mass, maximal muscle strength,
neuromuscular activation and rapid muscle force characteristics on the arthritic side
compared to the healthy side in hip OA.
2.3.3 Radiological findings
In clinical practice, frontal, anteroposterior radiograph of the pelvis demonstrates the
degree of hip joint OA. Other hip radiograph protocols include the anterior-posterior
radiograph centered on one hip and the hip profile of Lauenstein (Adam et al. 2008).
The cardinal radiographic features of OA include the formation of osteophytes on the
joint margins or in ligamentous attachments, the narrowing of the joint space associated
with sclerosis and cysts of subchondral bone and the altered shape of the head of the femur
(Goker et al. 2000, Lequesne et al. 2004). The identification of OA on plain x-rays means that
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there is already full thickness cartilage loss and even bone-on-bone contact. These
radiographic findings occur relatively late in the course of OA.
There are several classification systems for assessing the severity of hip OA (Rejman et
al. 2004). Classically the radiological classification criteria of hip OA in epidemiological
studies have relied on the characteristic radiographic changes described by Kellgren and
Lawrence in 1958. Based on the results of more recent studies, K-L grade appears to remain
a useful OA definition (Kellgren and Lawrence 1957, Reijman et al. 2004). Radiographic K-L
grading of the severity of hip OA is based mainly on narrowing of the joint space and bone
changes as follows: grade 0 as normal; 1 as possible narrowing of joint space and possible
osteophytes; 2 as definite narrowing of joint space and definite osteophytes; 3 as marked
narrowing of joint space, definite osteophytes and some deformity of femoral head and 4 as
gross loss of joint space, large osteophytes and marked deformity of femoral head.
New physical methods for early diagnosis of OA are under intensive development
(Vasara et al. 2005, Hannila et al. 2007, Jurvelin et al. 2008). Magnetic Resonance Imaging
(MRI) has emerged as an excellent modality for detection of OA when the plain
radiographs indicate no disease or mild disease and the patient’s symptoms are out of
keeping with the apparent severity of disease (Hall and Tyler 1995). MRI can detect large
focal articular cartilage lesions that cannot be detected on plain film (Boegard et al. 1998,
Cibere 2006). Articular cartilage lesions of the hip are not accurately diagnosed by standard
MRI alone differing from the lesions of the knee. Part of the reason is that the cartilaginous
surfaces of the femoral head and acetabulum are not well differentiated. Moreover, the
articular cartilage thickness is extremely thin, measuring only 1 to 2 mm in diameter
compared to 7 mm in the retropatellar cartilage (Watanabe et al. 2002). However, MRI can
be a more accurate diagnostic tool in cartilage pathology as an alternative to arthroscopy.
Schmidt et al. (2003) were able to detect chondral abnormalities with fairly accurate
sensitivity  and  specificity.  Traction  on  the  hip  during  MRI  could  also  improve  cartilage
visualisation (Nakanishi et al. 1999). Special techniques such as a water-excitation 3D
double-echo steady-state sequence have also been shown to provide increased conspicuity
of cartilage lesions (Knuesel et al. 2004). However, this technique is not routinely used in
clinics.
2.3.4 Criteria for diagnosis
The diagnosis  of  hip OA can be  radiographic,  clinical  or  based on a  combination of  these
two (Arokoski et al. 2012). The American College of Rheumatology (ACR), when
diagnosing hip OA has preferred the combined radiographic and clinical criteria for use
(Arokoski et al. 2012, Altman et al. 1991). According to the ACR the clinical criteria for hip
OA  consists  of  pain  in  the  hip  joint  region  within  the  previous  month  and  radiographic
joint changes evident in radiographs (Altman et al. 1991) (Table 2).
Table 2. Combined clinical (history, physical examination, laboratory) and radiographic classifi-
cation criteria for osteoarthritis of the hip, tradition format of ACR*.
Hip pain
        and
At least 2 of the following 3 features
        ESR < 20 mm / hour
        Radiographic femoral or acetabular osteophytes
        Radiographic joint space narrowing (superior, axial, and / or medial)
*This classification method yields a sensitivity of 89% and a specificity of 91%.
ESR = erythrocyte sedimentation rate.
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However,  many  authors  have  suggested  use  of  a  clinical  method  (not  focusing  to  radio-
graphic changes) to diagnose hip OA in epidemiological studies (Altman 1991, Birrell et al.
2001, Arokoski et al. 2000, Heliövaara et al. 1993a). The studies recommended using clinical
variables,  such  as  pain  location  or  duration,  hip  ROM,  age  or  aggravating  movement.
Among the different clinical criteria, diminishing hip ROM is the most common component
used to indicate the presence of hip joint OA. This is because the hip joint ROM has shown
to be a sensitive marker of the radiographic severity of OA (Arokoski et al. 2004).
2.4 TREATMENT OF HIP OSTEOARTHRITIS
There  is  no  cure  for  hip  OA  or  treatment  proven  to  slow  OA  progression.  The  main
treatment goal for patients with hip OA, therefore, is considered to be reducing joint pain
and physical disability. Treatment of hip OA is a combination of pharmacological, non-
pharmacological and surgical modalities (Arokoski et al. 2012, Hochberg et al. 2012, Vignon
2006, Zhang et al. 2008, Zhang et al. 2010) (Figure 2). Physiotherapy and occupational
therapy  are  regarded  to  be  important  components  of  any  therapeutic  program  for  OA.
These non-pharmacological treatments are as important as drug treatment in hip OA
(Arokoski et al. 2012, Hochberg et al. 2012, Vignon 2006, Zhang et al. 2008, Zhang et al.
2010). Pharmaceutical treatment should not be used as the sole treatment of OA (Arokoski
et al. 2012, Hochberg et al. 2012, Vignon 2006, Zhang et al. 2008, Zhang et al. 2010). The
main  indication  for  hip  arthroplasty  is  pain  that  cannot  be  controlled  by  conservative
means.
2.4.1 Conservative treatment
2.4.1.1 Patient education
Patient education and weight loss are generally used as primary therapeutic approaches in
the treatment of patients with primary OA (Arokoski et al. 2012, Hochberg et al. 2012, Vi-
gnon 2006, Zhang et al. 2008, Zhang et al. 2010). As part of a comprehensive treatment plan,
subjects  with  hip OA need to  receive  information on the  disease.  This  gives  the  patient  a
coping strategy to remain active despite pain and disability. Books, videos, pamphlets and
newsletters can be used as educational material. It has also been shown that periodic tele-
phone support interventions by lay personnel promoting self-care for patients with OA is
associated with relief of joint pain and improved physical function and the authors con-
cluded that telephone contact is cost-effective intervention in OA (Rene et al. 1992,
Weinberg et al. 1993).
2.4.1.2 Weight loss
Body weight has shown to be a risk factor for functional decline in OA of the hip (Dekker et
al. 2009). Treatment guidelines (Arokoski et al. 2012, Hochberg et al. 2012, Vignon 2006,
Zhang et al. 2008, Zhang et al. 2010) recommend different weight loss programs similar to
those used in knee OA to improve joint pain and function. However there are no controlled
studies on the effects of weight loss on hip OA symptoms.
Bariatric surgery is currently the only evidence-based approach to marked weight loss in
obese individuals (Buchwald et al. 2004). However, there is currently limited literature to
evaluate the role of bariatric surgery in hip and knee OA. A recent systematic review
demonstrated that bariatric surgery, as part of a comprehensive weight management
strategy with subsequent marked weight loss may lead to improved hip and knee pain and
function in obese patients with hip or knee OA (Gill et al. 2011). However, this review
identifies the need for randomized controlled trials to clarify the role and indicators for
supporting treatment by bariatric surgery.
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2.4.1.3 Physical therapy
Many physical modalities i.e. different thermal (e.g. cryotherapy, thermotherapy (ultra-
sound and short wave diathermy) and electromagnetic modalities [e.g. Transcutaeous Elec-
trical Nerve Stimulation (TENS) or laser) have been used for the alleviation of symptoms in
knee and hip OA. However, these treatment methods appear to have no benefit for people
with hip OA (Arokoski et al. 2012).
2.4.1.4 Occupational therapy
Occupational  therapy  plays  a  central  role  in  the  management  of  hip  OA  patients  with
functional limitations (Arokoski et al. 2012, Hochberg et al. 2012, Vignon 2006, Zhang et al.
2008, Zhang et al. 2010). The occupational therapist may be able to improve the patient’s
ability  to  perform daily  activities  and to  teach them the principles  of  energy conservation
and joint protection (Minor 1999, Hochberg et al. 1995). Environmental modifications and
adjustments of workstation furniture at home and in the workplace have been evaluated.
Different assistive devices i.e. raised toilet seats, grab rails / wall bars, seat cushions, a riser
to adjust seat height and dressing stick appear to be useful in helping patients to cope with
routines of daily living.
2.4.1.5 Drug treatment
Paracetamol is shown to be effective in the treatment of hip OA pain (Hochberg et al. 2012,
Vignon et al. 2006, Zhang et al. 2008, Zhang et al. 2010, Arokoski et al. 2012). It has also
shown to improve pain at rest and to be better tolerated than nonsteroidal anti-
inflammatory drugs (NSAIDs) (Bradley 1991). To avoid side-effects the dose of paracetamol
> 3g / day should not be exceeded (Zhang et al. 2010). If the efficacy of paracetamol is not
adequate, NSAIDs are recommended. NSAIDs (conventional and COX-2 selective) are
effective and widely used to reduce pain and to improve function in patients with hip OA
(McCormack 2011, Bingham et al. 2011). Due to serious cardiovascular and gastrointestinal
side  effects  of  all  the  NSAIDs,  they should be  used in  the  lowest  effective  dose  and their
long-term use should be avoided, if possible (Gabriel et al. 1991, Graham et al. 2005).
Opioids are conditionally recommended in patients who have had an inadequate response
to initial therapy. Opioid analgesics are recommended for patients who are either not will-
ing to undergo or had contraindications for total joint arthroplasty and have failed to re-
spond to medical therapy (Arokoski et al. 2012).
2.4.1.6 Exercise therapy
Current international guidelines for the treatment of hip OA recommend therapeutic exer-
cise, land or water-based, to be included in management strategies (Arokoski et al. 2012,
Hochberg et al. 2012, Vignon 2006, Zhang et al. 2008, Zhang et al. 2010). Exercise interven-
tion aims to alleviate the structural and functional impairments that accompany the pa-
thologies, rather than addressing the pathology itself. Currently, there is a lack of data to
support the putative benefits of exercise programmes in relieving pain associated with hip
OA (van Baar et al. 1999, Pisters et al. 2007, Hernandez-Molina et al. 2008, Fransen et al.
2009, Fransen et al. 2010, McNair et al. 2009, Escalante et al. 2010). Most randomized con-
trolled trials include patients with both knee and hip OA. It  is difficult to differentiate be-
tween these two entities and often patients with hip OA tend to be a minority in the sample
(van Baar et al. 1998, Hopman-Rock and Westhoff 2000, Foley et al. 2003, Hoeksma et al.
2004, Lin et al. 2004, Ravaud et al. 2004, Cochrane et al. 2005, Veenhof et al. 2006, Fransen et
al. 2007, Hinman et al. 2007, Pisters et al. 2010). Only two randomized controlled trials pub-
lished to date restricted recruitment to people with symptomatic hip OA (Tak et al. 2005,
Fernandes et al. 2010). Tak et al. demonstrated a favorable and significant short-term effect
of exercise on pain in hip OA and Fernandes et al. showed significant improvement in
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WOMAC physical function. The details of the results from previous randomized studies on
the effects of exercise in hip OA are given in table 3.
Researchers have also stated that there has been a lack of detailed exercise programs spe-
cifically for patients with hip OA. Only one therapeutic program (Fernandes et. al. 2010)
and one multimodal treatment program, including therapeutic exercises (Bennell et al.
2011), have been published.
A number of studies have compared the cost-effectiveness of pharmacological therapies
for OA (Zabinski et al. 2001, Gillette and Tarricone 2003). In contrast to operative treatment
of hip OA (total hip replacement), that has shown to be cost-effective (Jenkins et al. 2013),
little is known about the cost-effectiveness of non-pharmacological or non-operative treat-
ments, such as exercise, in hip OA.
2.4.2 Surgical treatment
Surgical intervention is required when there is a significant level of pain that limits normal
functional activities of daily living such as the ability to walk, stand, negotiate stairs, climb
in and out of a car and put on shoes and socks. Surgical options depend on the diagnosis,
severity of OA, patient age and activity level, patient occupation, patient medical health
and patient expectations (Eskelinen et al. 2010). Surgical options are grouped to five main
categories; arthroscopy, arthrodesis, osteotomy, pelvic osteotomy and hip joint arthroplasty
(Moscowitz et al. 2007).
Arthroscopy is a less invasive tool to diagnose and treat hip pathology. Its indications in-
clude labral tears, capsular laxity, chondral injury and ligament tears avulsion. Less com-
monly they can include management of osteonecrosis, inflammatory synovial processes,
infection and possibly early to mild OA (Kelly et al. 2003).
Osteotomies  of  the  pelvis  and  /  or  femoral  osteotomies  can  alter  force  transmission
through the hip joint and thus potentially influence clinical symptoms and the course of the
OA process. The underlying diagnoses in which one would consider an osteotomy include
young patients with secondary OA from hip dysplasia and residual deformities from
childhood conditions such as Perthes disease and slipped capital femoral epiphysis (Millis
et al. 1996).
Total hip arthroplasty (THA) is considered to be one of the most beneficial surgical pro-
cedures on health-related quality of life that currently performed (Wiklund and Romanus
1991, Laupacis et al. 1993,). It has also shown to be cost-effective (Jenkins et al. 2013). There
is no standard care randomized controlled trial for THA in existence. However, there are a
large  number  of  head to  head comparisons  between different  types  of  prosthesis  and un-
controlled follow up studies (Fizpatric et al. 1998, Faulkner et al. 1998). A systematic review
of 118 uncontrolled follow-up studies identified that the percentage of patients free from
pain at the end point ranged 43.2% (95% CI 34% to 49%) to 84.1% (95% CI 46% to 100%) de-
pending upon the type of prosthesis (Fizpatric et al. 1998).
Marked improvements in physical function, social interaction, and over-all health have
been demonstrated after THA (Laupacis et al. 1993). Different procedures of pre and post-
operative physical therapy and rehabilitation programs have been evaluated to improve the
outcome of surgery. There is little evidence to support the use of preoperative education
over and above standard care to improve postoperative outcomes in patients undergoing
hip replacement surgery, especially with respect to pain, function and length of hospital
stay (McDonald et al. 2004). However, perioperative exercise programs are proven to im-
prove functional recovery of subjective stiffness, hip strength and walking speed after THA
(Wang et al. 2002, Gilbey et al. 2003). Also a postoperative home program of physical ther-
apy or treadmill training with partial body-weight support is effective in improving hip
muscle strength, walking speed and the functional activity (Sashika et al. 1996, Hesse et al.
2003).
18
Figure 2. Treatment guidelines for hip OA in Finland. The conservative non-pharmacological
interventions  should  be  recommended  for  all  patients.  Redrawn  with  modifications  from
Arokoski et al. (2012).
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3  Aims of the study
The first  aim of  this  study was to  examine potential  risk  factors  hip OA.  The second aim
was to study factors associated with self-reported pain and physical function in patients
with  hip  OA  and  to  identify  deeper  determinants  of  disability  and  pain  in  hip  OA.  The
third aim was to evaluate the effect of exercise training on pain, functional ability and
healthcare costs in hip OA.
The detailed goals of the present series of studies can be outlined as follows:
1. To examine potential risk factors for hip OA in a 22-year prospective population-
based study (Article I).
2. To determine factors associated with self-reported pain and physical function in pa-
tients with hip OA. The potential factors assessed were age, education, depression,
life satisfaction, smoking, duration of sports activities, radiologic score of hip OA,
body mass index, comorbidites and duration of knee pain were also analysed (Arti-
cle II).
3. To assess the short-term and long-term effects of strengthening, land-based exercise
on hip OA taking into account both impairment (pain, functional limitations) and the
financial burden  (utilisation of medical and rehabilitation services and drug use)
caused by this disease (Article III).
4. To assess factors related to OA in the prediction of pain and physical and mental
function  in  a  two  year  randomized  controlled  trial  among  patients  with  hip  OA
(Article IV).
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4 Methods
4.1 STUDY POPULATION AND STYDY DESING
4.1.1 The prospective population-based study (Article I)
Between 1978 and 1980, a sample of 8000 people, representative of the Finnish population
aged 30 years or over, was drawn from the population register and invited to participate in
a cross-sectional study on health, the Mini-Finland Health Examination Survey (Aromaa et
al. 1989). In brief, 7217 subjects (90 % of the sample) participated in the screening phase of
the study, which comprised questionnaires, interviews and standard laboratory tests and
clinical examination. The examination, methods and the diagnosis of hip OA have been
described in detail elsewhere (Heliövaara et al. 1993a, Aromaa et al. 1989, Mäkelä et al.
1993, Aho K 1989).
The questionnaires were checked and the interviews were performed by specially
trained nurses. Information concerning educational level (years), smoking history (never-
smoked, ex-smoker, smoker), alcohol intake (expressed as absolute alcohol in grams/week)
and level of physical activity (inactive, irregularly active, regularly active) was elicited by
means of standard questionnaires. Body height and weight were measured and BMI was
calculated  by  dividing  body  weight  (kg)  by  body  height  squared  (m2). The subjects were
asked to  attend a  clinical  examination if  they had experienced any difficulties  in  walking
due  to  hip  pain  during  the  previous  month  or  if  they  were  found  to  have  difficulty  in
performing the function tests, for example, when asked to squat or climb stairs. At the
clinical examination stages 3-6 months later, specially trained physicians carried out the
clinical examinations according to a standardised written protocol.
Between 2000 and 2001, another cross-sectional population study on health in a
representative sample of Finnish men and women, the Health 2000 Survey, was conducted
(Aromaa et al. 1989) (Figure 3). The Health 2000 Survey was designed to have the same
protocol and assessments as the Mini-Finland Health Survey. All participants of the Mini-
Finland Health Survey who were alive in 2000 and living in or around any of the five major
regional cities were invited for re-examination in conjunction with the Health 2000 Survey.
Altogether 1286 former participants were invited and 909 of these participated in the
follow-up study. At baseline these subjects were on average 42 years old (SD 8 years, range
30 to 72 years). At follow-up their mean age was 63 years (SD 8 years, range 50 to 94 years).
After exclusion of individuals with hip OA at baseline and those who were retired, 840
subjects remained (371 males and 469 females) and constituted the present study
population (Figure 3). All participants signed a written consent and the study was
approved by the Ethical Committee for Epidemiology and Public Health in the hospital
district of Helsinki and Uusimaa, Finland.
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Figure 3. The flow of activities during the Mini-Finland Health Survey and the Health 2000
Survey follow-up examination in 2000-01.
POPULATION
Sample of 8000 Finnish men
and women aged 30 years or
older
Screening examination at
baseline in 1978-80
Screening examination by mobile clinic in-
cluding questionnaires of education, work-
load, smoking, physical activity, alcohol in-
take, interviews of symptoms and measure-
ments of body height and weight, 7212 sub-
ject (90%) participated
Follow up examination in 2000-
01
Clinical examination using same
methods as at baseline
Medical history
Symptom history
Physical health status
Clinical examination 3-6
months later
Invited n=1286 Partici-
pated n=909 Accepted
n=840
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4.1.2 Randomized controlled trial (Articles II, III, IV)
4.1.2.1 Subjects
The subjects for the randomized controlled trial (120 males and females, aged from 55 to 80
years) were recruited from the city of Mikkeli, Finland, and the surrounding area. The re-
cruitment was carried out primarily by an advertisement in a local newspaper (n=113) and
to a lesser degree from specialists’  clinics (n=2) or general practitioners’  clinics (n=5) (Figure
4). The recruitment period took place from August 2005 to February 2006. The subjects were
included in the study if they were 50 – 80 years of age and willing to participate in a study
lasting for two years and they had unilateral or bilateral hip OA with K-L grade ǃ 1 (X-ray
examination less than 3 years old) and pain experienced in the hip region (groin and lateral
hip region) within the preceding month as indicated in the clinical criteria of the ACR
(Altman et al. 1991). The exclusion criteria were THA, rheumatoid arthritis, cognitive im-
pairment, a major surgical operation within the preceding six months in the lower limb or
lower back, an acute or sub-acute lower back pain and cardiovascular or pulmonary disease
or other chronic diseases that would prevent full participation in the training program.
Randomization was performed using the stratified block randomization procedure in
order to balance subjects for gender and age (Figure 4). The number of strata was four
(gender and age groups: 55-67 and 68-80 years) and patients were randomized into three
blocks  (block  size  n  =  40).  Prior  to  randomization  to  the  combined  exercise  plus  general
practitioner  group  and  to  general  practitioner  group,  a  physician  specialising  in  physical
and rehabilitative medicine gave a 1-hour lecture on the basic principles of non-operative
treatment of hip OA. The combined exercise and general practitioners care group received
12 supervised 45 minute exercise sessions once a week at baseline and four additional
booster sessions at a time point one year later between the 12th and 13th month of follow-up.
A primary care physiotherapist supervised exercise sessions consisting of 10 participants at
a given time. Once the physiotherapist was certain that the participants had mastered the
exercises, a recommendation was made to perform the specific exercises using the same
protocol three times per week for two years. The exercise program was developed with
common training principals, modified to suit patients of hip OA (Peloquin et al. 1999, Rog-
ind et al. 1998). Each training session consisted of a warm-up session (marching in place
and leg raises to the front,  back and side) then strengthening and stretching sessions. The
intensity of the strengthening exercises was the same for each participant. The subjects
were  recommended  to  perform  the  exercises  with  maximal  effort  in  order  to  achieve  the
highest possible movement velocity. Stretching exercises were done to the point of mild
tension and relaxation as the subject held the stretch. The participants in the combined ex-
ercise plus general practitioner care group also received normal routine care offered by
their own general practitioner including analgesics and physiotherapy.
The participants in the general practitioner care group received standard care [normal
routine care offered by their own general practitioner (analgesics and physiotherapy)].
Outcome variables were assessed at study entry and at 3, 6, 12, 18 and 24 month visits.
The flowchart of the study is presented in Figure 4. The protocol was approved by Mikkeli
Central Hospital Research Ethics Committee. All participants provided a written consent.
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GP = general practitioner
THA = total hip arthroplasty
Figure 4. Flowchart of the study.
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Lost to follow up:
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12 months’  follow-up
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1 other disease
THA (2)
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(n=57)
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THA (1)
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(n=57)
Lost to follow up:
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THA (2)
24 months’  follow-up
(n=56)
Lost to follow up:
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THA (3)
Analyzed (n=57)
Participated in all follow ups
(n=55)
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(n=53)
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Excluded
(n=13)
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4.2 ASSESSMENT OF RISK FACTORS AND OUTCOME MEASURES
4.2.1 Assessments in the prospective population-based study (Article I)
4.2.1.1 Assessment of leisure time physical activity
Leisure time physical activity was assessed by one item from a self-administered
questionnaire. The subjects were classified into three categories as follows:
1. Little physical exercise: mostly reading, watching television, listening to the radio,
going to the cinema or restaurants or doing tasks that do not require much physical
exertion.
2. Irregularly physical exercise and/or in connection with some hobbies or as the main
pastime  or  in  addition  to  Group  1:  fishing,  hunting,  gardening,  going  on  family
outings fairly regularly or taking some other form of exercise occasionally.
3. Regular physical exercise: as the main pastime or in addition to the Groups 1 and 2:
some form of physical exercise regularly or fairly regularly, e.g. running, skiing,
cycling, ball games, swimming, gymnastics, weight lifting regardless of whether
these were done competitively, as a hobby or to improve physical condition.
4.2.1.2 Assessment of physical workload
Physical  workload  was  assessed  by  one  item  from  a  self-administered  questionnaire.  The
subjects were classified into six categories as follows:
1. Light sedentary work: mainly consisting of sitting at a table, by a machine, etc. and
involving only light manual work, e.g. intellectual work, studying, sedentary office
work, handling light objects.
2. Other sedentary work: mainly sedentary, but involves occasionally handling fairly
heavy objects, e.g. industrial work on a production line.
3. Light work standing or moving: mostly standing work without cumbersome
movements  or  moving from one place  to  another  without  carrying heavy burdens,
e.g. shop assistant, crane operator, laboratory work, office work or teaching all
requiring some mobility.
4.  Medium-heavy work involving movement:  involves  a  great  deal  of  mobility  and a
certain  amount  of  stooping  down  or  carrying  light  objects,  also  work  involving
walking up and down stairs or fairly rapid motion over rather long distances, e.g.
light industrial work, forest surveying, messenger work.
5.  Heavy manual  work:  either  mostly  standing work involving regular  lifting of  light
objects or lifting and carrying heavy objects, drilling, excavating, hammering etc.,
but with some sitting or standing, e.g. work in heavy engineering or manufacturing,
construction work, using or assembling heavy tools, goods or parts, agricultural
work using machines.
6. Very heavy manual work: mostly consisting of continuous or fairly continuous
heavy movement, often done without interruption for long periods, e.g. carrying
furniture, forestry work (felling trees), heavy non-mechanised agricultural work,
fishing with heavy tackle, heavy construction work, manual excavation.
4.2.1.3 Assessment of injuries
Injuries sustained since the baseline examination were classified by a physician according
to the 8th edition of the International Classification of Diseases on the basis of all available
medical history, symptoms and clinical findings during medical examination.
Musculoskeletal injuries were taken into account only if they had led to a permanent
damage or to any continued impairment or complaint.
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4.2.1.4 Assessment of other risk factors
Age (years), sex, education (years), smoking (never smoked, ex-smoker, smoker) and
alcohol intake (g/week) were assessed by a self-administered questionnaire. Body height
and  weight  were  measured  and  BMI  was  calculated  by  dividing  body  weight  by  body
height squared (kg/m2).
4.2.1.5 Diagnosis of hip osteoarthritis
Specially trained physicians undertook the clinical examinations and diagnosed hip OA
according to a standardised written protocol (Heliövaara et al. 1993a, Aromaa et al. 1989,
Mäkelä et al. 1993). The clinical diagnosis of hip OA was made on the basis of disease histo-
ries, symptoms and clinical findings according to standard criteria (Table 4). The physicians
were unaware of the potential predictor variables recorded at the baseline. For the present
study the definite and probable diagnoses were combined into one diagnostic group. The
sensitivity of the screening procedure for hip OA was 100% and a satisfactory agreement
(kappa (Ύ) 0.44) has been found between the clinical and radiological diagnosis of hip OA,
used in the Mini-Finland survey (Heliövaara et al. 1993a). The agreement between definite
clinical and radiological hip OA diagnosis (K-L grading scale 2 –  4) has been proved to be
moderate (Kaila-Kangas et al. 2011). The Ύ value was 0.66 (95% CI 0.29 to 1.00).
In  the  Health  2000  Survey  there  were  two  physicians  in  each  of  the  five  regional  field
teams. The quality assurance program comprised four separate days during which the
repeatability of the clinical diagnosis of hip OA was tested across the field teams. For this
all together 173 volunteers, aged 45-82, were recruited from outside the survey sample.
Two physicians always chosen from two separate field teams independently examined each
subject. The Ύ-value for the repeatability was 0.49 (95% CI 0.09 – 0.90) for OA in the left hip
(with a prevalence of 2.3% in both the first and second examinations). Similarly, the Ύ-value
was 0.61 (95% CI 0.26 – 0.96) for OA in the right hip (with a prevalence of 2.3% and 2.9% in
the two sets of examinations respectively).
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Table 4. Diagnostic criteria for hip OA in the clinical examination of the Mini-Finland Health
Survey and the Health 2000 Survey.
4.2.2 Assessments in randomized controlled trial (Articles II, III, IV)
4.2.2.1 Assessment of physical activity
Habitual conditioning physical activity was assessed using a leisure time physical activity
history developed in the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study (Lakka
and Salonen 1987). Leisure-time physical activity was assessed from 12-month history
modified from Minnesota Leisure Time Physical Activity Questionnaire (Taylor et al. 1978).
The  checklist  included  the  most  common  leisure-time  physical  activities  of  middle-aged
Finnish men and women, selected on the basis of a previous population study in Finland
(Mälkiä et al. 1988). For each activity performed, the subjects were asked to record the fre-
quency (number of sessions per month), average duration (hours and minutes per session)
and  intensity  (scored  as  0  for  recreational  activity,  1  for  conditioning  activity,  2  for  brisk
conditioning activity and 3 for competitive, strenuous exercise).
The  intensity  of  physical  activity  was  expressed  in  metabolic  units  (MET,  or  metabolic
equivalents of oxygen consumption). One metabolic unit corresponds to an energy expen-
diture of approximately 1 kcal per kilogram of body weight per hour, or an oxygen uptake
of 3.5 ml per kilogram per minute.
Documented history of previous hip arthroplasty
but no convincing evidence of diagnosed hipos-
teoarthritis.
OR
Typical symptoms of hip osteoarthritis AND
either of the following (even in the absence of
clinical findings in the current examination):
•  history of previously diagnosed hip
  osteoarthritis without documentation;
•  documented previous diagnosis of hip
  osteoarthritis but no grounds for the diagnosis
  given.
OR
Clinical findings suggesting hip osteoarthritis
(slightly restricted extension or inner or outer
rotation or at least moderately restricted
abduction-adduction) but no corresponding
history.
Documented history of previously diagnosed
hip osteoarthritis or hip arthroplasty due to os-
teoarthritis based on convincing findings.
OR
At least moderate restrictions in extension
(limitation over five degrees) or in inner rotation
(maximal range less than 20 degrees) or in outer
rotation (maximal range less than 30 degrees),
especially if combined with tenderness associ-
ated with movement.
OR
Slight restrictions in extension (limitation less
than five degrees) or in inner rotation (maximal
range 20–30 degrees) or in outer rotation
(maximal range 30–40 degrees) or at least mod-
erately restricted abduction-adduction (maximal
range
less than 50 degrees) AND either of the follow-
ing:
•  documented history of previously diagnosed
  hip osteoarthritis but no grounds for the
  diagnosis given;
•  typical symptoms of hip osteoarthritis
  (stiffness, pain when moving after inactivity,
  pain during prolonged strain).
Definite Probable
Hip osteoarthritis
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4.2.2.2 Assessment of depression and life satisfaction
The Beck Depression Inventory (BDI) with scores from 0 to 63 was used to assess possible
depression. The cutoff point for clinically significant depression was set at 15 or over, which
has been found to have good sensitivity (.835), specificity (.813), positive predictive value
(.968) and negative predictive value (.419) in screening major depression (Beck 1961). Life
Satisfaction (LS) scale was included to assess mental well-being. For each item participants
chose the statement that best described their experience. The sum scores were analysed
continuously or dichotomously (the satisfied croup had scores 4-11 and the dissatisfied
group had 12-22) (Koivumaa-Honkanen 1998).
4.2.2.3 Assessment of other possible risk factors
Demographic characteristics collected included information on the sex, age, working status,
duration of hip symptoms, presence of knee OA and/or knee pain, comorbidites and BMI.
4.2.2.4 Assessment of pain
Self-reported pain was assessed by using the visual analogue scaled format of the WOMAC
OA index, designed specifically for people with hip or knee OA (Bellamy 1988). The visual
analogue scaled version allows the patients to estimate the symptoms by marking an X on a
100  mm  long  line  (the  beginning  of  the  line  =  no  symptoms,  the  end  of  the  line  =  worst
possible symptoms). Subscale pain consists of 5 questions. The mean score of hip pain was
generated by summing the coded responses and then dividing by the number of items.
4.2.2.5 Assessment of physical function
The  specific  physical  function  of  self-reported  diseases  was  determined  by  using  the
subscale of physical function of the WOMAC OA index that consists of 17 questions
concerning physical function (Bellamy et al. 1988). The mean score of hip function was
generated by summing the coded responses and then dividing by the number of items.
Self-reported generic physical function was determined using the physical function part
of the RAND-36 questionnaire. The instrument contains exactly the same questions as the
36-item Short-Form Health Survey (SF-36) (Ware and Sherbourne 1992). The reliability and
construct validity of the RAND-36, as a measurement of the health-related quality of life
(HRQOL) in the Finnish general population, has been established (Aalto et al. 1999). The
RAND-36 survey comprises 8 multi-item dimensions: general health, physical function,
mental health, social function, vitality, bodily pain and physical and emotional role
function.  Each  subscale  ranges  from  0  to  100  with  higher  scores  indicative  of  a  better
HRQOL.
The passive hip flexion and the hip internal rotation ROM measurements were deter-
mined by using 2-arm goniometry (Arokoski et al. 2004). The passive movement, including
stretching, was done until the firm or bony end was reached and/or discomfort limited the
motion or compensatory movement occurred.
The objective physical function was measured by using a battery of tests performed in a
random order (the six-minute walk test (6-MWT), the 10-meter walk test (10-MWT), the
timed up & go test (TUG test), the sock test and the leg extensor power measurement) as
follows;
The six-minute walk test, a reliable, valid and safe test, was used to quantify the
participant’s walking ability (Guyatt et al. 1985). The 6-MWT is measure of both gait speed
and function as well as endurance exercise capacity. The score recorded was the total
distance travelled (in meters) during 6 minutes.
The 10-meter walk test, a measure of gait velocity, was performed indoors on a 10-meter
long track and the time spent to complete the walk, in seconds, was measured (Watson
2002).
The timed up & go test is a performance based measure, which is clinically well
established as a measurement of function for knee OA (Podisalo and Richardson 1991).
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Participants are asked to stand up from the chair, walk 3 m, turn, walk back and sit down
quickly and safely. The time, in seconds, required to complete the test was recorded.
The sock test (Strand and Wie 1999), for evaluating activity limitation in patients with
musculoskeletal  pain,  was  used  to  describe  the  functional  loss  caused  by  hip  OA.  The
patient is asked to sit on a high bench, with both hands, one on each side, grabbing the toes
with the fingertips of both hands. The foot must not touch the bench and should be in the
air at all times during the test. After testing each leg once, the patient is given a score on the
most restricted performance (scores are valued from 0 to 3).
The extensor power of the lower limb was recorded by using the leg extensor power rig
(Concept 2, dynamic strength training). The subject was seated in the upright position with
arms folded. Comfortable extension of at the knee in conjunction with full depression of the
foot pedal determined the seat position. The subject was instructed to depress the foot
pedal as hard and as fast as possible. The measure of leg extensor power was expressed as
relative power (absolute power divided by body weight (W/kg)). The one-week inter-day
inter-tester and intra-tester reproducibility was 0.982 and 0.996, respectively (Robertson et
al. 1998).
4.2.2.6 Radiological assessment
The same physician specialising in radiology, analysed the degree of hip OA from antero-
posterior radiograph of the hip joint. The mean age of the radiographs was 8.7 ± 10.3
months. The K-L method of classification was used as described in page 14 (Kellgren and
Lawrence 1957). The intra-rater reproducibility of K-L grading has been established as
being high (.85 – .91) (Sun et al. 1997).
4.2.2.7 Assessment of the use of medication
The use of analgesic (paracetamol and weak opioid (tramadol, codeine)) and NSAIDs for
the  treatment  of  hip  OA  were  assessed  using  patients’  reports.  The  original  drug  use
assessment was based on the following questions: 0 = not using, 1 = using, but less
frequently than once a week, 2 = using 1 to 4 times a week, 3 = using 5 to 6 times a week, 4 =
using daily (the dose of drugs taken was not evaluated). In the final analysis the drug use
categories (drug use in a week) were computed as follows; 0 = not using, 1 = using, but less
than daily, 2 = using daily.
4.2.2.8 Assessment of health care costs
The evaluation of direct health care costs was assessed by recording the number of visits to
a physician and the number of visits of physiotherapy due to hip OA, when not part of the
intervention and the number of total hip replacements. The use of physiotherapy, again not
as part of the intervention, was calculated as sum score including either exercise
physiotherapy and/or physical therapy modalities (e.g. thermal modalities, transcutaneous
electrical nerve stimulation, acupuncture) as follows; 0 = not using, 1= using either exercise
physiotherapy or physical therapy modalities, 2 = using both exercise physiotherapy and
physical therapy modalities. The questionnaire also included other aspects of
physiotherapy e.g. osteopathy, hip traction and also inquired if steroid injections had been
administered in the hip region. These accounted for only very few visits and therefore only
physiotherapy, including the exercise physiotherapy or physical therapy modalities, were
taken into consideration in the analysis.
The direct medical costs (supervised group therapy, doctor visits,  use of physiotherapy
when not part of the intervention and total hip replacement) were evaluated, but indirect
costs, such as absence from work were not estimated. The direct costs were calculated as
the mean cost per patient, in Euro, over the 24 month period based on the supervised group
exercise therapy costs in the Mikkeli Health Care Center (Ollikainen 2008) and healthcare
unit costs (doctor visits, physiotherapy when not part of the intervention and total hip
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replacement) in Finland 2006 (Hujanen et al. 2008). The costs of total hip replacement
surgery were analysed separately.
4.3 STATISTICAL METHODS
4.3.1 The prospective population-based study (Article I)
Multivariate logistic regression analyses were used to estimate the risk of hip OA according
to the baseline risk factors and potential confounding factors. Relative risks were estimated
as adjusted odds ratios (ORs) with 95% confidence intervals (CIs). In order to study the
effect modification, the first-degree multiplicative interaction terms of workload and injury,
one by one, were entered into the logistic regression model. Associations with p-values of
less than 0.05 were considered statistically significant. The statistical significance of the
interactions was tested against the likelihood ratio test and expressed as exact p-values. All
analyses  were  performed  using  the  SAS  System  for  Windows,  version  9.1  (SAS  Institute,
Inc., Cary, NC).
4.3.2 Randomized controlled trial (Articles II, III, IV)
The  differences  in  baseline  characteristics  between  the  groups  (combined  exercise  plus
general practitioner care and general practitioner care only) were evaluated using
independent samples t-test for continuous variables and Fisher’s exact test for categorical
variables. Associations with p-values of less than 0.05 were considered statistically
significant. The analyses were conducted using SPSS for Windows 17.0.
At baseline Pearson’s coefficients for correlation were used for continuous variables and
Spearman’s coefficients for correlation were used for the ordinally-scaled education
variable to study associations between explanatory and outcome variables. Analysis of
covariance (ANCOVA) was used to identify independent risk factors for self-reported pain,
self-reported disease-specific physical function and self-reported generic physical function
by entering all explanatory variables that correlated (p < 0.01) with the outcome variables
into the ANCOVA models. The RAND-36 general health, mental health, social function,
vitality,  bodily  pain  and  physical  and  emotional  role  function  and  the  WOMAC  subscale
stiffness were not entered into the models of self-reported mobility measures because of
possible co-linearity with pain and physical function. The data are presented as means with
standard deviations (SDs) and standard errors or medians with ranges or frequencies and
percentages depending on the outcome variables and the types of statistical analysis.
A 20% reduction in the primary outcome (WOMAC pain) in response to the exercise
intervention was considered clinically relevant. The SD for WOMAC pain was assumed to
be 16.5mm based on previous studies (Tubach et al. 2005). Using these assumptions the
appropriate sample size was 120 patients (60 per group) with an alpha equal to 0.05 and
power equal to 80% and a 10% loss to follow-up.
Repeated measures analysis of variance was used to examine the differences over time
between  the  combined  exercise  and  general  practitioner  care  group  and  the  general
practitioner care group, followed by post hoc comparisons of groups at each time point.
The post hoc comparisons were based on the estimated marginal mean. The analyses for
the WOMAC, RAND-36 and secondary outcomes, except for the sock test, were adjusted
for  gender,  age  at  baseline,  radiologic  K-L score  of  hip OA,  the  number  of  comorbidities,
the  existence  of  knee  OA  or  knee  pain  and  the  duration  of  hip  symptoms.  Due  to  the
somewhat unexpected differences between the study groups in the WOMAC-pain at
baseline, the repeated measures analyses of variance for the WOMAC, RAND-36 and
secondary outcomes were additionally adjusted for the baseline values of the response
variable. Randomly missing data in the longitudinal set-up was imputed using the ‘last
observation  carried  forward’  principle  before  the  analysis  (WOMAC,  RAND-36  and
secondary outcomes) in order to follow the intention to treat principle. Results related to
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the WOMAC, RAND-36 and performance-based outcome score (except for the sock test)
are presented as adjusted estimated marginal means, standard errors and 95% CIs.
The analysis of occasions of health services ’usage and health services’  direct costs were
carried out using the non-parametric Mann-Whitney U-test for continuous variables and
the Fisher’s exact test for categorical variables. Fisher’s exact test was used to investigate
whether distributions of categorical drug use variables differed from one another.
To identify the predictors of disability and pain in hip OA, the intervention and control
groups were combined in the analyses. The baseline and two-year follow-up data on all 118
participants were analysed together; group randomization was considered as one of the
possible predictors for the outcomes. The outcome variables were self-reported disease-
specific pain and physical function subscales of the WOMAC and RAND-36 measured at 0,
3, 6, 12, 18 and 24 month follow-up. The possible explanatory variables were age, gender,
educational level (secondary school examination; no vs. yes), comorbidities (no vs. yes),
prevalent obesity (BMI < 30.0 kg/m2 vs. BMI ǃ 30.0 kg/m2), working status (employed; no vs.
yes), the radiological grade of hip OA (K-L 1 vs. K-L 2-4) (Kellgren et al. 1963), the duration
of hip symptoms (years), knee symptoms (no vs. yes), study group (control group vs.
intervention group) and habitual conditioning physical activity (hours per week) that was
not part of the exercise intervention. The associations of possible explanatory variables with
the outcome variables were assessed by multivariate linear mixed models in which the
correlation structure of data due to the multiple measurements per individual could be
taken into account.
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5 Results
5.1 THE PROSPECTIVE POPULATION-BASED STUDY (ARTICLE I)
5.1.1 Characteristics of subjects
The distributions of age (mean, SD, range) and other characteristics (number, percentage) of
the participants at baseline of the Mini-Finland Survey in 1978-80 and at follow-up in 2000-
2001 are presented in Table 5. After 22 years of follow-up, hip OA was diagnosed in 17 men
(4.9%) and in 24 women (5.1%).
5.1.2 Definition of risk factors
Table 6 shows the odds ratios for having hip OA, adjusted for age and sex and for age, sex
and all other covariates. Heavy manual labour was a statistically significant predictor of the
development of hip OA even adjusted for all covariates. In addition, individuals who had
had a musculoskeletal injury that had led to permanent damage or long-term impairment
had a statistically significantly higher risk of developing hip OA than those without such an
injury. Education, BMI, smoking, alcohol intake and leisure time physical activity were not
associated with the risk of developing hip OA (Table 6). None of these factors modified the
associations of heavy labour or major injury with the risk of hip OA (data not shown).
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Table 5. Characteristics of the subjects in the prospective population-based study.
*Excluded from the follow-up analyses.
Characteristics
People not
invited
(%)
People in-
vited, but
not partici-
pated (%)
All partici-
pants at
baseline in
1978-1980
(%)
Participants
at follow-
up in 2000-
2001 (%)
Age (years)
   Mean
   SD
   Range
52.9
14.4
30-95
48.3
11.4
30-77
51.3
14.2
30-95
42.5
9.0
30-72
Sex
   Men
   Women
2797     (47)
3142     (53)
139    (38)
230    (62)
3322  (46)
3895  (54)
386    (42)
523    (58)
Education (years)
    0-9
   10-12
    > 13
4312     (73)
1138     (19)
489        (8)
222    (60)
93      (25)
54      (15)
4905  (68)
1506  (21)
806    (11)
371    (41)
275    (30)
263    (29)
Body mass index (kg/m2)
   <25.0
   25.0-29.9
   >30.0
2590      (44)
2370      (40)
979        (16)
172    (47)
148    (40)
49      (13)
3305  (46)
2815  (39)
1097  (15)
543    (60)
297    (33)
69       (7)
Physical work load
    not working*
    light sedentary
    other sedentary
    light standing / movements
    fairly light / medium heavy
    heavy manual
    very heavy manual
2118      (36)
735        (12)
201         (3)
772        (13)
1010      (17)
823        (14)
280         (5)
181   (26)
86     (23)
13      (4)
60     (16)
76     (21)
35      (9)
4        (1)
2273  (32)
1151  (16)
250     (3)
1031  (14)
1266  (18)
950    (13)
296     (4)
60       (7)
330    (36)
36       (4)
199    (22)
180    (20)
92      (10)
12       (1)
Smoking
    never smoked
    ex-smoker
    smoker
3336     (56)
1215     (21)
1388     (23)
192    (52)
79      (21)
98      (27)
4009  (55)
1505  (21)
1703  (24)
481    (53)
211    (23)
217    (24)
Alcohol intake (g/week)
     0
     1-49
     50-249
     >250
2914     (49)
2382     (40)
210        (4)
433        (7)
163    (44)
157    (42)
21       (6)
28       (8)
3296  (45)
3080  (43)
285     (4)
556     (8)
219    (24)
541    (60)
54       (6)
95      (10)
Leisure time physical activity
    little physical exercise
    irregular physical exercise
    regular physical exercise
2292     (39)
2873     (48)
764       (13)
122    (33)
173    (47)
74      (20)
2636  (37)
3477  (48)
1094  (15)
222    (24)
431    (47)
256    (28)
Injury
    No
    Yes
5287     (89)
652       (11)
341    (92)
28       (8)
6484  (90)
733    (10)
856    (94)
53       (6)
Hip OA
    No
    Yes*
5593     (94)
346        (6)
357    (97)
12       (3)
6848  (95)
369     (5)
898    (99)
11       (1)
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Table 6. Adjusted ORs for risk factors of hip OA.
OR = odds ratio, CI = confidence interval.
*Mean 41.8, SD 8.4, range 30-72 (OR per increment by one SD).
Risk factor
Number of
subjects
examined
Number
of OA
cases
(%)
Adjusted for
sex and age
OR (95 % CI)
Adjusted for all
covariates
OR (95 % CI)
Age (years)* 840 41 1.4 (1.0-2.0)
Sex
   Men
   Women
371 (44)
469 (56)
17 (41)
24 (59)
1.0
1.9 (0.8-4.5)
Education (years)
    0-9
   10-12
    > 13
331 (39)
255 (31)
254 (30)
17 (41)
15 (37)
9   (22)
1.0
1.3 (0.6-2.8)
0.8 (0.4-1.9)
1.0
1.6 (0.7-3.5)
1.5 (0.5-4.1)
Body mass index
   <25.0
   25.0-29.9
   >30.0
507 (60)
272 (33)
61   (7)
20 (49)
17 (41)
4   (10)
1.0
1.4 (0.7-2.8)
1.4 (0.4-4.3)
1.0
1.3 (0.6-2.8)
1.1 (0.3-3.6)
Physical work load
    light sedentary
    other sedentary
    light standing / movements
    fairly light / medium heavy
    heavy manual
    very heavy manual
327 (39)
36   (4)
196 (23)
178 (21)
91   (11)
12   (2)
10 (24)
1   (2)
6   (15)
13 (32)
11 (27)
0
1.0
0.9 (0.1-7.2)
1.0 (0.3-2.7)
2.4 (1.0-5.7)
4.6 (1.8-11.5)
1.0
1.1 (0.1-10.0)
1.2 (0.4-3.4)
3.1 (1.2-8.0)
6.7 (2.3-19.5)
Smoking
    never smoked
    ex-smoker
    smoker
435 (52)
197 (23)
208 (25)
22 (54)
10 (24)
9   (22)
1.0
1.0 (0.5-2.4)
1.0 (0.4-2.2)
1.0
1.0 (0.4-2.4)
0.9 (0.4-2.3)
Alcohol intake (g/week)
     0
     1-49
     50-249
     >250
185 (22)
508 (61)
53   (6)
94   (11)
11 (27)
24 (59)
0
6   (15)
1.0
0.9 (0.4-1.9)
1.5 (0.5-4.7)
1.0
1.1 (0.5-2.4)
2.2 (0.6-7.7)
Leisure time physical activity
    little physical exercise
    irregular physical exercise
    regular physical exercise
199 (24)
395 (47)
246 (29)
9   (22)
21 (51)
11 (27)
1.0
1.1 (0.5-2.4)
0.9 (0.4-2.3)
1.0
1.2 (0.5-2.9)
1.1 (0.4-2.8)
Injury
    No
    Yes
793 (94)
47   (6)
34 (83)
7   (17)
1.0
3.5 (1.4-8.7)
1.0
5.0 (1.9-13.3)
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5.2 THE RANDOMIZED CONTROLLED TRIAL (ARTICLES II, III, IV)
5.2.1 Characteristics of subjects at baseline
Figure 4 shows the participant flow and reasons for withdrawal and loss to follow-up at
different stages of the study. Baseline characteristics of the participants are shown in Table
7 and 8. In general, the patients in the combined exercise and general practitioner care and
general practitioner care groups did not differ at baseline, but WOMAC pain was
statistically significantly higher in the general practitioner care group than in the combined
exercise and general practitioner care group.
Table 7. Baseline characteristic in the randomized controlled trial.
Variables Valid percent
Gender
   Male 30.0
   Female 70.0
Working status
   No-longer employed 72.0
   Part-time employed 11.0
   Employed 16.9
Radiographic grade of hip osteoarthritis
   Kellgren-Lawrence grade 1 41.7
   Kellgren-Lawrence grade 2 42.5
   Kellgren-Lawrence grade 3 13.3
   Kellgren-Lawrence grade 4 2.5
Knee osteoarthritis 33.9
Comorbidities
   No chronic disease 41.5
   One chronic disease 44.9
   Two or more chronic diseases 13.6
Overweight
   No (body mass index < 25 kg/m²) 19.7
   Yes (body mass index  25 kg / m²) 80.3
Depression
   No depression (Beck depression inventory score <15#) 88.6
   Depression (Beck depression inventory score  15#) 11.4
Life satisfaction
   Satisfied with life (Life Satisfaction scale = 4-11)
   Unsatisfied with life (Life Satisfaction scale = 12-20)
79.7
20.3
#Beck depression inventory scores range from 0 to 63.
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5.2.2 Factors affecting self-reported pain and disability at baseline (II)
The bivariate correlations of pain, self-reported disease specific physical function and self-
reported generic physical function with all independent variables are shown in Table 9. The
number of comorbidites and the duration of knee pain and LS explained 22% of self-
reported pain. The number of comorbidites, passive hip flexion and the TUG test explained
20% of self-reported disease specific physical function whereas the passive hip flexion, 6-
MWT and educational level explained 25% of self-reported generic physical function.
Table 8. Self-reported and physical performance measures at baseline.
Variables                                                                            Mean ±SD                         Range
Symptoms of hip osteoarthritis
   Pain index from WOMAC* (mm) 25.2 ± 18.0 2-75
   Stiffness index from WOMAC* (mm) 35.3 ± 24.4 0-90
   Physical function index from WOMAC* (mm) 26.8 ± 19.7 0-83
Components of health related quality of life (HRQOL)
   Physical functioning from RAND-36† 62.3 ± 20.2 15-100
   Role physical from RAND-36† 51.3 ± 39.0 0-100
   Bodily pain from RAND-36† 57.5 ± 18.3 13-100
   General health from RAND-36† 56.1 ± 17.3 5-95
   Vitality from RAND-36† 66.0 ± 16.8 10-100
   Social functioning from RAND-36† 80.5 ± 18.5 38-100
   Role emotional from RAND-36† 67.0 ± 39.3 0-100
   Mental health from RAND-36† 78.4± 15.0 36-100
Physical performance tests
   10-meter walk test (time (s)) 5.9 ± 1.4 3.5-14.3
   6-minute walk test (distance (m)) 480.8 ± 85.2 222.0-709.0
   Timed up & go test (time (s)) 7.0 ± 1.4 4.5-13.3
   Leg extensor power test (W/kg)$ 1.1 ± 0.3 0.36-2.26
   Passive hip flexion (angle (º))¶ 97.4 ±16.8 60-130
   Passive hip internal rotation (angle (º))¶ 28.8 ± 8.2 10-47
*Western  Ontario  and  McMaster  Universities  OA  Index  ranges  from  0  mm (no  symptoms)  to
100 mm (maximal symptoms).
†RAND-36 is the Finnish version of the Short-Form Health Survey (SF-36) assessing wellbeing
and ranging from 0 (maximal symptoms) to 100 (no symptoms).
$Leg extensor power was measured by Concept 2-dynamometer.
¶Passive hip flexion and internal rotation of more painful hip was measured by goniometry.
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Table 9. Pearson’s coefficients for correlation between dependent (outcome) and independent
(explanatory) variables.
Variables WOMACpain#
WOMAC
physical
function#
RAND-36 physi-
cal function†
Kellgren-Lawrence grade of hip OA .027 .016 -.018
Body mass index (kg/m²) .137    .252**   -.290**
 Comorbidites    .369**    .313**   -.220*
Duration of knee pain (years) .198* .195*  -.104
 Age (years) .123 .149 -.138
 Education (years)   -.276**   -.264**     .291**
 Beck depression inventoryμ       .196       .131  -.184
 Life satisfaction scale¤    .299** .204    -.319**
    Smoking (years) -.102 -.097 -.019
 Duration of sport activities (years) .163 .079 .101
Physical performance tests
Leg extensor power (W/kg)$ -.191*   -.277**   .256**
Passive hip flexion (angle (º))¶   -.261**   -.286**  .239**
Passive hip internal rotation (angle (º))¶ .050 -.010 .090
 Sock test° .134 .243** -.303**
 10-meter walk test (time (s)) .233* .208* -.338**
 Timed up & go test (time (s))   .251**   .282** -.344**
 6-minute walk test (distance (m))   -.277**  -.286**   .417**
*p < 0.05  **p < 0.01.
#Western Ontario and McMaster Universities OA Index ranges from 0 mm (no symptoms) to
100 mm (maximal symptoms).
†RAND-36 is the Finnish version of the Short-Form Health Survey (SF-36) assessing wellbeing
and ranging from 0 (maximal symptoms) to 100 (no symptoms).
Kellgren-Lawrence grade (0 - 4).
μBeck depression inventory scores from 0 to 63. Cut-off point for clinically important depression
was 15 or over.
¤Life satisfaction scale; 4-11 (satisfied group scores) 12-20 (dissatisfied group scores).
$Leg extensor power was measured by Concept 2-dynamometer.
¶Passive hip flexion and internal rotation of more severe hip was measured by goniometry.
°Sock test scale from 0 to 3; 0 (no difficulties with simulating sock wearing) up to 3 (remark-
able difficulties with simulating sock wearing).
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5.2.3 Effectiveness of exercise therapy (III)
Adherence to supervised exercise sessions was 86% during the first intervention year that
contained 12 supervised sessions during the first three months and 58% during the second
intervention year that contained four additional sessions at the 12 month time point.
Adherence to the exercise program was commendable during the first year of follow-up
with the  mean (range)  of  performed exercise  sessions  being 2.5  sessions  per  week during
months 0-3, 2.1 sessions per week during months 4-6 and 1.9 sessions per week during
months 7-12. A slight decline was observed during the second year of follow-up with the
mean being 1.7 sessions per week during months 13-18 and 1.6 during months 19-24.
According to self-reported disease-specific pain (WOMAC), there was no overall statisti-
cally significant effect of exercise intervention on self-reported disease-specific pain (Figure
5) at two years and no statistically significant difference between groups was observed at
the different time points.
The overall effect of the exercise intervention on self-reported disease-specific function
(WOMAC) was statistically significant (p=0.04) (Figure 6). At the 6 and 18 months’  time
points a statistically significant difference in favor of the combined exercise and general
practitioner care group was observed in the self-reported disease-specific function. No
differences were detected between the groups in self-reported physical function scale score
of RAND-36.
Figure 5. Self-reported disease-specific pain (WOMAC (mean)).
Combined exercise and general practitioner care group
General practitioner care group
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Figure 6. Self-reported disease-specific functioning (WOMAC (mean)).
Combined exercise and general practitioner care group
General practitioner care group
p = 0.02      , p = 0.04
No  statistically  significant  differences  between  groups  were  observed  in  BMI  at  the
separate time points. Furthermore, there were no significant differences between the
groups in measures of physical performance, including the passive internal rotation and
flexion of the hip joint, the extensor power of lower limb, in the distance walked in the 6-
MWT, in the sock test, 10-MWT and in the TUG tests.
No differences were detected between the groups in the use of paracetamol or weak
opioids. At the 12 (p = 0.03) and 18 (p = 0.01) month time points a statistically significant
difference in favour of the combined exercise and general practitioner care group was
observed in the use of NSAIDs. In the combined exercise and general practitioner care
group at the 12 month and 18 month time points 59% (66%) were not using, 31% (25%)
were using less than daily and 10% (9%) were using daily NSAIDs. In the general
practitioner group at the 12 month (and 18 month) time point 36% (39%) were not using,
55% (50%) were using less than daily and 7% (11%) were using daily NSAIDs.
5.2.4 Cost consequences (III)
Cost consequences of combined exercise and general practitioner care versus general
practitioner care alone are shown in Table 10. Neither the number of visits to the doctor nor
the mean costs of those visits due to hip OA differed significantly between the groups. The
use of physiotherapy due to hip OA was significantly lower in the combined exercise and
general practitioner care group compared to the general practitioner care group during the
second year of follow-up. In addition, the mean cost of physiotherapy per patient was
significantly lower in the combined exercise and general practitioner care group as
compared to the general practitioner care group.
5.2.5 Predictors of pain and physical function in two-year follow-up (IV)
Table 11 describes the associations of baseline variables with the outcome variables. Lower
disease specific pain and better physical functioning (WOMAC) were predicted by
supervised  exercise  training  (p  =  0.010,  p  =  0.004),  a  higher  level  of  habitual  conditioning
physical activity (p = 0.048, p = 0.044), a higher educational level (p = 0.004, p = 0.012), the
absence of comorbidities (p = 0.042, p = 0.019) and the absence of additional knee OA (p =
0.017, p = 0.021) respectively.
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Better general physical function score (RAND-36) was predicted by supervised exercise
training (p = 0.026), a higher level of habitual conditioning physical activity (p = 0.012), a
higher educational level (p = 0.007) and the absence of additional knee OA (p = 0.015).
The following predictors for the RAND-36 physical component summary scores were
supervised exercise training (p = 0.034), a higher educational level (p = 0.009) and the
absence of knee OA (p = 0.043). Younger age (p = 0.003) was associated with better RAND-
36 mental component summary scores. Gender, the radiological grade of the hip joint,
obesity or being retired predicted none of the outcomes characterising pain or physical
functioning in hip OA.
44
Ta
bl
e 
10
. 
N
um
be
r 
of
 t
he
 d
oc
to
r 
vi
si
ts
 (
du
ri
ng
 t
he
 f
ir
st
 a
nd
 t
he
 s
ec
on
d 
ye
ar
s)
 a
nd
 u
se
 o
f 
ph
ys
io
th
er
ap
y 
se
rv
ic
es
 a
ss
oc
ia
te
d 
w
ith
 h
ip
 O
A
 a
nd
 t
ot
al
hi
p 
ar
th
ro
pl
as
ty
 s
ur
ge
ry
 a
nd
 h
ea
lth
 c
ar
e 
sy
st
em
 d
ir
ec
t 
co
st
s 
du
ri
ng
 t
he
 t
w
o 
ye
ar
 f
ol
lo
w
-u
p.
   
   
   
   
   
   
C
om
b
in
ed
 e
xe
rc
is
e 
an
d
 g
en
er
al
 p
ra
ct
it
io
n
er
   
   
   
   
   
   
   
   
   
   
   
   
  c
ar
e 
(n
 =
 5
5
-5
8
)
 G
en
er
al
 p
ra
ct
it
io
n
er
 c
ar
e
   
   
   
   
 (
n
 =
 5
1
-5
8
)
O
u
tc
om
e 
va
ri
ab
le
(w
it
h
 u
n
it
 c
os
ts
(€
))
°
Ti
m
e
(m
o)
M
ed
ia
n
 (
ra
ng
e)
/
n
u
m
b
er
 o
f
p
at
ie
n
ts
M
ea
n
(S
E)
M
ea
n
 (
S
E)
co
st
 p
er
p
at
ie
n
t 
(€
)°
M
ed
ia
n
(r
an
g
e)
/
n
u
m
b
er
 o
f
p
at
ie
n
ts
M
ea
n
 (
S
E)
M
ea
n
 (
S
E)
co
st
 p
er
p
at
ie
n
t 
(€
)°
p

p
(m
ea
n
 c
os
t
p
er
 p
a-
ti
en
t)
°%
0-
3
S
up
er
vi
se
d 
gr
ou
p-
th
er
ap
y¤
(6
0.
04
€)
12
96
.1
0-
12
0 
(0
 –
 4)
0.
38
D
oc
to
r 
vi
si
ts
*
(8
1.
5€
)
12
-2
4
0 
(0
 –
 3)
0.
5 
(0
.1
)
0.
5 
(0
.1
)
77
.1
(1
3.
8)
0 
(0
 -
10
)
0 
(0
 –
 8)
0.
8 
(0
.2
)
1.
1 
(0
.2
)
15
2.
0
(2
8.
7)
0.
05
0.
07
0-
12
1 
(0
 –
 6)
0.
05
Ph
ys
io
th
er
ap
y§
(9
1.
3€
)
12
-2
4
0 
(0
 –
 2)
1.
3 
(0
.2
)
0.
4 
(0
.1
)
15
7.
7
(2
3.
4)
2 
(0
 –
 8)
1 
(0
 –
 5)
2.
0 
(0
.3
)
1.
3 
(0
.2
)
29
8.
5
(3
5.
0)
<
0.
00
1
0.
00
2
C
os
ts
 w
ith
ou
t 
to
ta
l
hi
p 
re
pl
ac
em
en
t
0-
24
33
0.
9
(3
0.
1)
45
4.
5
(5
4.
7)
0.
12
0-
12
2
3
0.
68
To
ta
l h
ip
 r
ep
la
ce
-
m
en
t
(8
08
9.
6€
)
12
-2
4
3
  
  
  
70
9.
6
(3
05
.8
)
5
11
55
.7
(4
33
.8
)
0.
49
0.
51
Al
l c
os
ts
 p
er
 p
at
ie
nt
10
66
.3
(3
31
.5
)
  
 1
40
6.
3
(4
41
.8
)
0.
13
45
°A
n 
an
al
ys
is
 o
f 
he
al
th
 c
ar
e 
pr
ov
id
er
s 
di
re
ct
 c
os
ts
 w
as
 c
ou
nt
ed
 a
s 
m
ea
n 
co
st
 p
er
 p
at
ie
nt
 (
€)
 f
ro
m
 t
he
 0
 t
o 
24
 m
on
th
 t
im
e 
pe
ri
od
 b
as
ed
on
 t
he
 s
up
er
vi
se
d 
gr
ou
p 
ex
er
ci
se
 t
he
ra
py
 c
os
ts
 in
 t
he
 M
ik
ke
li 
H
ea
lth
 C
en
tr
e 
an
d 
he
al
th
 c
ar
e 
un
it 
co
st
s 
(v
is
its
 t
o 
th
e 
do
ct
or
, 
ph
ys
io
th
er
ap
y
an
d 
to
ta
l h
ip
 r
ep
la
ce
m
en
ts
) 
in
 F
in
la
nd
.
D
iff
er
en
ce
 in
 t
he
 n
um
be
r 
of
 v
is
its
 t
o 
th
e 
do
ct
or
, 
su
m
 s
co
re
 o
f 
th
e 
us
e 
of
 p
hy
si
ot
he
ra
py
 a
nd
 T
H
A
 (
ye
s/
no
) 
du
ri
ng
 t
he
 f
ir
st
 a
nd
 s
ec
on
d
ye
ar
 o
f 
th
e 
fo
llo
w
-u
p 
be
tw
ee
n 
th
e 
gr
ou
ps
 (
M
an
n-
W
hi
tn
ey
 U
-t
es
t 
an
d 
Fi
sh
er
’s
 e
xa
ct
 t
es
t)
.
%
D
iff
er
en
ce
 in
 t
he
 h
ea
lt
h 
ca
re
 p
ro
vi
de
rs
 d
ir
ec
t 
m
ea
n 
co
st
 p
er
 p
at
ie
nt
 d
ur
in
g 
tw
o 
ye
ar
 f
ol
lo
w
-u
p 
be
tw
ee
n 
th
e 
gr
ou
ps
 (
M
an
n-
W
hi
tn
ey
 U
-t
es
t)
.
¤ E
xe
rc
is
e,
 in
cl
ud
ed
 in
 in
te
rv
en
tio
n 
(1
2 
gr
ou
p 
ex
er
ci
se
 t
he
ra
py
 s
es
si
on
s 
fr
om
 0
 t
o 
3 
m
on
th
s 
an
d 
4 
gr
ou
p 
ex
er
ci
se
 t
he
ra
py
 s
es
si
on
s 
fr
om
 1
2 
to
 1
3
m
on
th
s)
.
*N
um
be
r 
of
 v
is
it
s 
to
 a
 d
oc
to
r 
co
nc
er
ni
ng
 h
ip
 O
A.
§ S
um
 s
co
re
 o
f 
ph
ys
io
th
er
ap
y 
vi
si
ts
 in
cl
ud
in
g 
ei
th
er
 e
xe
rc
is
e 
ph
ys
io
th
er
ap
y 
an
d/
or
 p
hy
si
ca
l t
he
ra
py
 m
od
al
it
ie
s 
as
so
ci
at
ed
 w
it
h 
hi
p 
O
A
(n
ot
 a
s 
pa
rt
 o
f 
th
e 
in
te
rv
en
tio
n)
.
46
Ta
bl
e 
11
.
Pa
ra
m
et
er
 e
st
im
at
es
 (
an
d 
th
ei
r 
95
 %
 C
Is
) 
fr
om
 m
ul
tiv
ar
ia
te
 li
ne
ar
 m
ix
ed
 m
od
el
s 
w
ith
 t
he
 f
ol
lo
w
in
g 
ex
pl
an
at
or
y 
va
ri
ab
le
s 
(o
ne
 m
od
el
pe
r 
de
pe
nd
en
t 
va
ria
bl
e)
 i
.e
. 
av
er
ag
e 
di
ff
er
en
ce
s 
in
 o
ut
co
m
e 
va
ri
ab
le
s 
of
 h
ip
 p
ai
n 
an
d 
fu
nc
tio
ni
ng
 b
et
w
ee
n 
gr
ou
ps
 o
f 
ca
te
go
ri
ca
l 
pr
ed
ic
to
rs
 a
nd
av
er
ag
e 
ch
an
ge
 p
er
 s
in
gl
e 
un
it
 o
f 
co
nt
in
uo
us
 p
re
di
ct
or
s.
P
ar
am
et
er
W
O
M
A
C
 p
ai
n
a
W
O
M
A
C
 f
u
n
ct
io
n
a
R
A
N
D
-3
6
 f
u
n
ct
io
n
b
R
A
N
D
-3
6
 P
C
S
b
R
A
N
D
-3
6
 M
C
S
b
A
ge
 (
pe
r 
10
 y
ea
rs
)
0.
90
(-
4.
57
–6
.3
5)
0.
12
(-
0.
48
–0
.7
1)
-0
.4
1
(-
1.
06
–0
.2
3)
-5
.1
0
(-
11
.0
0–
0.
79
)
-8
.2
5*
*
(-
1
3.
6
0–
-2
.9
1)
l
G
en
de
r 
(m
al
e 
vs
. 
fe
m
al
e)
2.
36
(-
4.
02
–8
.7
3)
1.
62
(-
5.
31
–8
.5
5)
1.
62
(-
5.
92
–9
.1
7)
-0
.1
2
(-
7.
02
–6
.7
8)
0.
20
(-
6.
05
–6
.4
5)
Ed
uc
at
io
n 
(e
le
m
en
ta
ry
 s
ch
oo
l v
s.
 s
ec
on
da
ry
sc
ho
ol
 o
r 
hi
gh
 s
ch
oo
l)
9
.6
1
**
(3
.1
5
–1
6.
0
7
)c
9
.0
7
*
(2
.0
5
–1
6.
0
9
)f
-1
0
.5
9
**
(-
1
8.
2
4–
-2
.9
4)
i
-9
.3
6*
*
(-
1
6.
3
5–
-2
.3
6)
k
-2
.9
1
(-
9.
24
–3
.4
2)
C
om
or
bi
di
tie
s 
(n
o 
vs
. 
ye
s)
-6
.3
0*
(-
1
2.
3
5–
-0
.2
4)
d
-7
.8
7*
(-
1
4.
4
5–
-1
.3
0)
g
5.
77
(-
1.
40
–1
2.
94
)
5.
10
(-
1.
46
–1
1.
67
)
2.
16
(-
3.
77
–8
.0
9)
Bo
dy
 m
as
s 
in
de
x 
(<
 3
0.
0 
kg
/m
² 
vs
. 
 
30
.0
kg
/m
²)
2.
51
(-
4.
27
–9
.4
8)
-0
.9
6
(-
8.
53
–6
.6
1)
5.
27
(-
2.
97
–1
3.
51
)
2.
97
(-
4.
57
–1
0.
52
)
-1
 4
9
(-
8.
32
–5
.3
3)
R
et
ir
ed
 v
s.
 e
m
pl
oy
ed
 o
r 
pa
rt
-t
im
e 
em
pl
oy
ed
0.
33
(-
7.
32
–7
.9
8)
3.
54
(-
4.
88
–1
1.
79
)
-1
.1
8
(-
10
.2
5–
7.
89
)
1.
46
(-
6.
83
–9
.7
6)
7.
48
(-
0.
01
–1
4.
97
)
R
ad
io
lo
gi
ca
l g
ra
de
 (
Ke
llg
re
n-
La
w
re
nc
e 
1 
vs
.
K
el
lg
re
n-
La
w
re
nc
e 
2-
4)
1.
58
(-
4.
58
–7
.7
5)
0.
74
(-
5.
95
–7
.4
3)
0.
93
(-
6.
35
–8
.2
2)
0.
07
(-
6.
60
–6
.7
4)
0.
39
(-
5.
65
–6
.4
3)
D
ur
at
io
n 
of
 h
ip
 s
ym
pt
om
s 
(y
ea
rs
)
0.
17
(-
0.
14
–0
.4
9)
0.
19
(-
0.
15
–0
.5
3)
-0
.1
2
(-
0.
50
–0
.2
5)
-0
.1
8
(-
0.
52
–0
.1
6)
-0
.2
6
(-
0.
57
–0
.0
4)
K
ne
e 
pa
in
  
(n
o 
vs
. 
ye
s)
-7
.6
2*
(-
1
3.
8
7–
-1
.3
6)
-8
.0
2*
(-
1
4.
8
1–
-1
.2
3)
9
.2
5
*
(1
.8
5
–1
6.
6
5
)
7
.0
0
*
(0
.2
3
–1
3.
7
7
)
2.
09
(-
4.
03
–8
.2
1)
G
ro
up
 (
in
te
rv
en
tio
n 
vs
. 
co
nt
ro
l)
-1
0
.1
3
*
(-
1
7.
8
7–
-2
.3
9)
-1
1
.5
8
**
(-
1
9
.4
0
–-
3
.7
7)
9
.3
1
*
(1
.1
4
–1
7.
4
7
)
8
.2
6
*
(0
.6
1
–1
5.
9
1
)
4.
86
(-
2.
60
–1
2.
32
)
C
on
di
tio
ni
ng
 p
hy
si
ca
l a
ct
iv
ity
 (
ho
ur
s/
w
ee
k)
-0
.4
8*
(-
0
.9
6
–
-0
.0
1)
e
-0
.3
9*
(-
0
.8
4
–0
.0
5)
h
0
.5
6
*
(0
.1
3
–1
.0
0)
j
0.
42
(-
0.
01
–0
.8
5)
0.
42
(-
0.
03
–0
.8
7)
*p
 <
 0
.0
5,
 *
*p
 <
 0
.0
01
.
47
a W
es
te
rn
 O
nt
ar
io
 a
nd
 M
cM
as
te
r 
U
ni
ve
rs
iti
es
 O
A
 I
nd
ex
 (
W
O
M
A
C
 (
m
m
))
.
b T
he
 F
in
ni
sh
 v
er
si
on
 o
f 
th
e 
Sh
or
t-
Fo
rm
 H
ea
lth
 S
ur
ve
y 
(S
F-
36
) 
su
bs
ca
le
s 
fo
r 
fu
nc
tio
n 
an
d 
Ph
ys
ic
al
 C
om
po
ne
nt
 S
um
m
ar
y 
(P
C
S
) 
an
d 
M
en
ta
l 
Co
m
-
po
ne
nt
 S
um
m
ar
y 
(M
CS
) 
sc
or
es
.
c 9
.6
1
hi
gh
er
 p
ai
n 
sc
or
e 
(0
 =
 n
o 
sy
m
pt
om
s,
 1
00
 =
 m
ax
im
al
 s
ym
pt
om
s)
 w
ith
 lo
w
er
 e
du
ca
tio
na
l l
ev
el
.
d 6
.3
0 
lo
w
er
 fu
nc
tio
na
l i
m
pa
ir
m
en
t 
w
ith
 n
o 
co
m
or
bi
di
tie
s.
e 0
.4
8
lo
w
er
 p
ai
n 
sc
or
e 
in
 r
el
at
io
n 
to
 in
cr
ea
se
 o
f c
on
di
ti
on
in
g 
ex
er
ci
se
 t
ra
in
in
g 
fo
r 
on
e 
ho
ur
 p
er
 w
ee
k.
f 9
.0
7 
hi
gh
er
 f
un
ct
io
na
l i
m
pa
ir
m
en
t 
w
ith
 lo
w
er
 e
du
ca
tio
na
l l
ev
el
.
g 7
.8
7 
lo
w
er
 fu
nc
tio
na
l i
m
pa
ir
m
en
t 
w
ith
 n
o 
co
m
or
bi
di
tie
s.
h 0
.3
9 
lo
w
er
 fu
nc
tio
na
l i
m
pa
ir
m
en
t 
in
 r
el
at
io
n 
to
 in
cr
ea
se
 o
f 
co
nd
iti
on
in
g 
ex
er
ci
se
 t
ra
in
in
g 
fo
r 
on
e 
ho
ur
 p
er
 w
ee
k.
i 1
0.
59
 h
ig
he
r 
fu
nc
tio
na
l i
m
pa
ir
m
en
t 
(0
 =
 m
ax
im
al
 s
ym
pt
om
s,
 1
00
 =
 n
o 
sy
m
pt
om
s)
 w
ith
 lo
w
er
 e
du
ca
tio
na
l l
ev
el
.
j 0
.5
6 
lo
w
er
 f
un
ct
io
na
l i
m
pa
ir
m
en
t 
in
 r
el
at
io
n 
to
 in
cr
ea
se
 o
f 
co
nd
iti
on
in
g 
ex
er
ci
se
 t
ra
in
in
g 
fo
r 
on
e 
ho
ur
 p
er
 w
ee
k.
k 9
.3
6 
hi
gh
er
 fu
nc
ti
on
al
 im
pa
ir
m
en
t 
w
ith
 lo
w
er
 e
du
ca
ti
on
al
 le
ve
l.
l 8
.2
5 
hi
gh
er
 m
en
ta
l i
m
pa
irm
en
t 
in
 r
el
at
io
n 
to
 in
cr
ea
se
 o
f 
10
 y
ea
rs
 o
f 
ag
e.
48
49
6 Discussion
6.1 THE PROSPECTIVE POPULATION-BASED STUDY (ARTICLE I)
6.1.1 Methodological considerations
One of  the  fortes  of  this  study is  its  design:  it  was  a  population-based,  prospective  study
with a long follow-up period extending up to 22 years. A limitation is that the diagnostic
criteria of the ACR were not applied. The explanation for this is that the baseline survey
was conducted more than two decades ago when the ACR criteria had not been devised. In
the follow-up examination, the original criteria of hip OA used in the Mini-Finland Health
Survey  were  conformed  to.  Hip  OA  was  diagnosed  by  specially  trained  physicians  who
applied uniform diagnostic criteria that took into account medical histories, symptoms and
the physical status of the hip joints assessed according to a standardised clinical procedure.
However, it is possible that there was some inconsistency between physicians in the diag-
nostics of hip OA. Therefore the repeatability of the diagnoses was tested across the field
teams in the Health 2000 Survey (follow-up) and repeatability shown to be acceptable. This
was as displayed in the previous national health examination survey using similar protocol
and the same diagnostic criteria (Heliövaara et al. 1993a). In the current survey, the agree-
ment between definite clinical and radiological diagnoses of hip OA proved to be moderate
(Kaila-Kangas  et  al.  2011).  The  results  of  the  present  study  may  therefore  differ  from  the
observations of previous studies, which have diagnosed hip OA on the basis of radio-
graphic findings.
The two-stage selection from the baseline examination to the invitation and subsequently
to the participation in re-examination may have attenuated the risk estimates. At the first
stage, factors associated with morbidity, and disability, such as old age, male sex, a lower
level of education, a history of very heavy manual labour and all obvious factors that are
more common in rural than urban settings, led to a decreased likelihood of re-examination.
At the second stage, obesity 22 years earlier was still associated with non-participation.
Consequently, the prevalence of major risk factors and the magnitude of the effects of the
risk factors may have lowered, whereas any severe bias in the other direction would have
barely registered.
6.1.2 Main findings
Physical loading related to heavy manual labour and permanent damage as a consequence
of any musculoskeletal injury proved to be independent risk factors for developing hip OA
in this population-based study.
Several studies have shown that farmers have a higher risk of developing hip OA than
other occupationally active men (Croft et al. 1992, Thelin and Holmberg 2007). Previous
studies have also suggested that lifting heavy objects is a significant risk factor for clinical
and radiological hip OA (Lievense et al. 2001, Jensen 2008, Kaila-Kangas et al.  2011). A
recent review concluded that there is moderate to strong evidence for a relationship
between heavy lifting and hip OA (Jensen 2008). However, the role of heavy workload in
the pathogenesis of hip OA has not been clarified. A widely accepted theory is that
susceptibility to OA may be the result of an interaction between systemic (such as genetics,
dietary intake, oestrogen use, and bone density) and biomechanical factors (such as muscle
weakness, obesity, heavy workload, and join laxity) (Felson et al. 2000).
OA may occur when activity is excessive or when a lower load acts on a vulnerable joint.
Considerable effort has been made over the years to describe the variety of forces that
contribute to the joint reaction force of the human hip (Bergman et al 2001, Arokoski et al.
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2000). Direct measurements of such forces are very cumbersome and to date are not
possible in humans. During slow walking the hip joint is loaded with approximately 3
times  body  weight  just  after  heel  strike,  with  forces  increasing  4  times  body  weight  just
before toe-off (Kabada et al. 1989). During running, forces equivalent to 7 to 8 times body
weight  are  transmitted  across  the  hip  joint  during  heel  strike  and  increase  to  a  value
slightly higher than that during toe-off (Kabada et al. 1989).
Cartilage damage attributable to trauma can compromise the ability of cartilage to
function and survive in the strenuous mechanical environment normally found in load-
bearing joints. Joint injury and subsequent joint instability, from loss of ligamental or
meniscal support, are known to be significant risk factors for knee OA (Radin et al. 1991). In
the Framingham study (Felson 1988) both males and females who had suffered major knee
injuries in the past were subsequently prone to develop knee OA. However, major injuries
leading to ligamental tears and cartilaginous damage are rare in the hip. Cross-sectional
studies (Heliövaara et al. 1993b, Cooper et al. 1998, Lau et al. 2000, Thelin and Holmberg
2007) have inferred that traumatic injuries might also give rise to hip OA. Nonetheless, the
findings  of  the  present  study  were  surprising:  individuals  who  had  sustained  traumatic
injuries  displayed  a  fivefold  risk  of  developing  hip  OA  during  the  follow-up  period.  A
closer inspection of the anatomical distribution of the traumatic injuries indicated that the
hip joint was only rarely directly affected in these cases. One possible explanation for this
finding might be that the cases were overloaded and under pressure at work and therefore
more liable to sustain traumatic injuries in a variety of parts of the body.
The hypothesis of our study was that, within 22 years of follow-up, excess body weight
would emerge as a strong independent risk factor for hip OA. However, the association of
obesity with increased risk of hip OA was not found. Although epidemiological studies
have observed the direct association of obesity with hip OA (Jiang et al. 2011), the results of
some studies are inconsistent (Heliövaara et al. 1993b, Hartz et al. 1986, Gelber 2003). It has
also been suggested that metabolic or inflammatory factors contribute to the relationship
between obesity and OA (Vuolteenaho et al. 2009). Recent research seems to be focused on
distinguishing specific phenotypes of OA by different pathogenic pathways (Bijlsma et al.
2011). These may reveal a new perspective and lead to a deeper understanding develop-
ment of OA helping to find new treatment strategies at an earlier stage.  It is hoped that
future research will clarify the potential role of systemic and local inflammatory and meta-
bolic factors associated with adipose tissue as contributors to the risk of hip OA.
6.1.3 Clinical implications
Working conditions and workplace ergonomics should be taken into account in order to
develop  strategies  aimed  at  the  prevention  of  hip  OA  and  its  medical,  functional  and
economic consequences. Using a preventative strategy to protect individuals from excessive
workloads could probably avoid many cases of hip OA.
6.2 RANDOMIZED CONTROLLED TRIAL (ARTICLES II, III, IV)
6.2.1 Methodological considerations
A particular strength of the present study was the design; a randomized controlled trial.
Moreover,  patients  included  had  all  been  diagnosed  with  hip  OA  prior  to  the  study  and
used interventions especially designed for hip OA. The subject groups had hip OA with
mild  to  moderate  symptoms,  as  indicated  by  relatively  low  WOMAC  scores  of  pain  and
physical function, which are commonly seen in patient groups in primary care (Lievense et
al. 2007). In addition, patients with hip OA with K-L grade 1 were included although grade
1 is not considered to be a definite indication of OA. This inclusion decision was taken be-
cause OA diagnosis is based not only on radiological but also on clinical symptoms as indi-
cated in the clinical criteria of the ACR (Altman et al. 1991). Although the patients scored
mild to moderate symptoms on the WOMAC, a total of 13 patients (11%) had to undergo
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total hip replacement surgery within the 2-year period. This indicates that the patients in-
cluded in the trial had noticeable symptoms for which they needed efficient treatment mo-
dalities.
Despite the appropriate randomisation and concealment of allocation, an unexpected dif-
ference in WOMAC-pain, one of the primary measures of the study, was observed between
the groups. Repeated measures ANCOVA was used to analyse the data. Treatment group,
measurement time (visit) and their interaction were used as fixed factors in the model.
WOMAC-pain at baseline was included in the model as continuous covariate and other
adjusting variables as fixed factors or covariates depending on their measurement scale.
Repeated measures analyses were used to adjust for the differences in the response vari-
able’s baseline values, in order to minimise the risk of bias.
The underlying study principle was that any possible result could be applied in primary
health care as well as in specialist clinics. Therefore, the intervention was accomplished as
collaboration between the rehabilitation clinic of a central hospital and the primary health
care organisation with the participants mainly being recruited from the primary health
care. Consequently, the study sample comprises a representative sample of patients with
hip OA and not those collected from patients attending orthopedic clinics. This can be
considered  as  a  genuine  strength  of  the  study.  It  was  also  important  that  the  exercise
programme could be performed without the requirement for specialist training equipment.
For practical reasons the exercise program was generic and not individually tailored for
each participant. Greater improvements may have been reached in self-reported function
and performance based outcome scores if more individualised and intensive strengthening
exercise treatment programmes had been used (Hinman et al. 2007).
The  majority  of  studies  evaluating  exercise  as  treatment  for  patients  with  OA  have
encountered difficulties in compliance with treatment by the subjects themselves (Williams
et al. 2008, Domino 2005). The low dropout rate is a major strength of this study. The
exercise programme was generally well tolerated, resulting in commendable adherence to it
especially during the first year. The mean of exercise sessions per week was 2.5 during
months 0-3, 2.1 during months 4-6 and 1.9 during months 7-12. A slight decline was
assessed during the second year of follow-up with the mean being 1.7 in months 13-18 and
1.6 in months 19-24. These exercise frequencies are below those recommended for the
study’s rehabilitation programme. For example, research has consistently shown that as
many as half of all patients with diagnosed hypertension do not follow their recommended
drug regime (Domino 2005, Williams et al. 2008). This issue manifests itself equally with
respect to exercise therapy and at worst, can nullify any conclusions about therapeutic
efficacy. The duration of the exercise period and the amount of individual exercises
performed per session would be sufficient in terms of evaluating the potential effect of
exercising (Feigenbaum and Polock 1999, Wernbom et al. 2007).
6.2.2 Main findings
The present randomized controlled trial showed slight benefits of improved self-reported
physical function but detected no significant effect on disease-specific pain during a two-
year follow-up. However, deeper analyses of the study in the same subjects provides
somewhat stronger evidence that exercise therapy can reduce pain and help maintaining
physical function in hip OA patients. This is because exercise training generally predicted a
lower presence of pain and better functional status in patients with hip OA. The weaker
evidence from the randomized controlled trial than from the latter analyses may be attrib-
utable to the relatively small study population. The smaller group lowers statistical power
to detect statistically significant effects in the intervention study. The more detailed analy-
ses of pain and physical function resulted in an improved outcome in the exercise therapy
group. The results emphasise exercise training to be beneficial in the management of hip
OA and are aligned with existing recommendations (Roddy et al. 2005, Hochberg et al.
2012).
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In this study, there was no significant difference in self-reported pain score between the
groups. However, participants in the combined exercise and general practitioner care group
used less NSAIDs compared to the general practitioner care group. The use of painkillers
may be a more objective indicator of long-term pain than pain symptoms. The difference
between the  groups was nearly  significant  at  the  6-month time point  and statistically  sig-
nificant  at  the  12  and  18-month  time  points;  the  second  year  of  follow-up.  These  results
support the view that exercise has a long-term pain-relieving effect in hip OA.
The minimal difference in WOMAC sub-scores of 0.67 – 0.75 points (scale 0 – 10) in abso-
lute values and 11 – 26% in relative values has been suggested necessary to achieve clinical
significance in rehabilitation studies (Angst et al. 2001, Fransen et al. 2008). In this study,
the mean difference in WOMAC physical function scores between the groups was 7.5 mm
(scale 0-100) at 6 months and 7.9 mm at 18 months, which can be considered relatively
small. Tubach et al. (2005) determined the minimal clinically significant improvement of
functional impairment in patients with knee and hip OA. They suggested that the statisti-
cally significant difference is predominantly a matter of sample size. Whereas a more diffi-
cult issue is whether an observed or estimated difference is clinically important. They as-
sessed that the minimal clinically important improvement in absolute (and relative) change
of WOMAC function subscale in knee and hip OA was –7.9mm (– 21.1%). In the present
study the mean statistically significant difference in the improvement of WOMAC function
index between the groups was about 8 mm (i.e. about 24% difference) at 6 and 18 months,
the difference could be considered clinically significant.
It was not possible to undertake a comprehensive cost-effectiveness analysis, because
only a limited number of direct medical costs and no indirect costs were assessed. Direct
medical costs due to supervised group therapy, visits to the doctor, physiotherapy and
THA are considered the most important expenses for the cost-effectiveness analysis. In this
trial the number of THAs was lower in the combined exercise and general practitioner care
group than in the general care group. However, the observed difference may be due to
chance  because  of  a  small  number  of  subjects  who  needed  THA  in  the  study  groups.  In
general, this study provides only weak evidence for the cost-effectiveness of exercise ther-
apy. This was because it did not include a sufficient number of subjects for comprehensive
cost-effectiveness analyses.
It was found that a higher educational level, the absence of comorbidities and additional
knee symptoms as well as being in the exercise therapy group predicted lower pain scores
and a better function during a two year follow-up. Furthermore cross-sectional analyses at
baseline indicated that educational level, life satisfaction, the duration of knee symptoms
and the  number  of  comorbidities  were  associated with self-reported pain and function in
hip OA.
Educational level and working status predicted a better outcome in the present longitu-
dinal study, whereas disease-related factors showed no or only a weak association with
pain and functional status. A recent study (Schäfer et al. 2010) demonstrated that socioeco-
nomic position (social, educational and occupational factors) had a significant impact on
functional outcome and response to hip replacement. The present study is the first to report
the association of socioeconomic position with pain and physical function prior to hip re-
placement among patients with hip OA.
The results of the present study suggest that comorbidities predict a poorer pain and
physical function outcome among the hip OA patient during a two-year follow-up. It was
also demonstrated that knee pain or knee OA, in addition to hip OA, are significant when
determining  the  factors  affecting  pain  and  functional  status.  This  is  the  first  longitudinal
study on these associations among patients with hip OA. It has been suggested that comor-
bidities and cognitive decline also increase limitations in activities in elderly patients with
OA (van Dijk et al. 2009). OA is one of the diseases with a high rate of comorbidities (Leite
et al. 2011).  There is evidence that as high as 68-85% of patients with OA have comorbid-
ities (Tuominen et al. 2007, van Dijk et al. 2009). Conditions that frequently occur alongside
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OA are diabetes, hypertension, depression and cardiovascular diseases (Lago et al. 2011)
and often comorbidities are related to disability (Marks and Allegrante 2002). Cognitive
impairment is frequently observed in the elderly but their prevalence and association with
limitations in activities have not been studied in patients with OA.
Leite and co-workers found, in a cross-sectional study, that hip OA patients often have
depression, metabolic syndrome and its components, which can worsen pain and physical
dysfunction (Leite et al. 2011). Dekker and co-workers indicated that comorbidities are im-
portant risk factors for functional decline among patients with hip or knee OA (Dekker et
al. 2009). Such results emphasise the requirement for assessing and treating those comor-
bidities in OA patients.
6.2.3 Clinical implications
A low educational level, life dissatisfaction and comorbidities were important determinants
of self-reported pain and physical dysfunction.  Factors explaining and predicting disability
and pain in hip OA are multidimensional and no single factor was identified as more sig-
nificant than others.
The present two-year randomized controlled trial shows that exercise therapy may
slightly improve self-reported physical function in individuals with hip OA. However, it is
unclear whether the improved physical function translates into true improvement in physi-
cal  performance or  reduced health  care  costs.  A higher  educational  level,  absence  of  knee
OA and comorbidities, supervised exercise training and habitual conditioning physical ac-
tivity predicted a lower existence of pain and a better functional status. The radiographic
severity of hip OA was associated with pain and disability in the prospective study.
The results of the present study emphasise the requirement for focusing not only on dis-
ease-specific impairment (e.g. radiological severity of hip OA) as well as general support
such as preventing the functional decline associated with the disease. This type of global
approach to rehabilitation, taking into account individuals background (education) and
comorbidities, is important when developing optimal treatment strategies for hip OA. The
results of this study provide additional evidence to support the view that clinical decisions
cannot be made only by radiographic findings of the hip joint alone; symptoms and physi-
cal function, of the patient suffering from hip OA, are also important factors.
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7 Conclusions
The principal findings of these studies (Papers I-IV) are:
I
Physical loading related to heavy manual labour and musculoskeletal injuries are inde-
pendent risk factors for developing hip OA. Working conditions and ergonomics should be
taken into account in the prevention of hip OA. (I).
II
Exercise therapy for hip OA had no significant effect on self-reported pain or generic physi-
cal health, but it slightly improved self-reported physical function in individuals with hip
OA. It is unclear whether the improved self-reported physical function translates into true
improvement in physical performance or reduced health care costs (III).
III-IV
Factors explaining and predicting disability and pain in hip OA are multidimensional and
no single factor was more significant than any other (II). Higher educational levels, absence
of knee OA and comorbidities, supervised exercise training and habitual conditioning
physical activity predicted a lower presence of pain and a better functional status in pa-
tients with hip OA (IV).
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and Effects of Exercise Therapy
The causes of hip osteoarthritis 
(OA) are heterogeneous with 
genetic, environmental and 
lifestyle-related risk factors 
influencing the development of 
the disease. Hip OA causes pain 
and disability and reduces the 
quality of life. In this thesis, risk 
factors for hip OA and effects 
of exercise therapy in hip OA 
were determined. Heavy manual 
work and injuries increased 
the risk of hip OA. Exercise did 
not effect on pain, but slightly 
improved function.
